Focal epilepsy, strict definition

FE_STRICT

partial epilepsy: A seizure caused by a localized disorder.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions not GE	518188
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints FE	9257
6. Filter based on genotype QC (FinnGen only)	8990

Control definitions (FinnGen only)

Control exclude: G6_EPLEPSY
Control conditions: not GE

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	FE_STRICT
CONTROL_EXCLUDE	G6_EPLEPSY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!GE
SEX
INCLUDE	FE
PRE_CONDITIONS
CONDITIONS	!GE
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Focal epilepsy, strict definition based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	83361	38369	44332
Only index persons	69676	32994	36682
Unadjusted period prevalence (%)
Whole population	1.17	1.10	1.24
Only index persons	1.31	1.21	1.40
Median age at first event (years)
Whole population	53.68	53.75	53.47
Only index persons	52.12	52.25	52.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8990	4427	4563
Unadjusted period prevalence (%)	1.83	1.57	2.09
Median age at first event (years)	55.76	51.28	60.12

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9257: Matched controls
92533

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

10.6

322.7

358

350

N03AX23

ATC

brivaracetam; systemic

+∞

313.3

299

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

96.9

311.7

162

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.8

311.2

748

1671

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

308.0

2107

9167

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

18.0

307.7

523

306

G40.10

ICD-10 Finland

Simple partial seizures

12780.2

307.7

1135

G41.9

ICD-10 Finland

Status epilepticus, unspecified

124.3

307.7

461

G40.89

ICD-10 Finland

Other epilepsy

3937.0

307.7

388

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

307.7

7661

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

307.7

417

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

5255.8

307.7

508

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.8

307.7

1496

4463

N03AB02

ATC

phenytoin; systemic

57.5

307.7

683

128

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

14.5

307.7

307

219

XA400

NOMESCO Finland

EEG

22.1

307.7

248

115

N05BA09

ATC

clobazam; oral

347.7

307.7

707

G40.9

ICD-10 Finland

Epilepsy, unspecified

2067.9

307.7

3716

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.3

307.7

1778

3998

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

14916.3

307.7

1297

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

45.9

307.7

678

159

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

+∞

307.7

399

N05CD08

ATC

midazolam; nasal, systemic

10.2

307.7

656

686

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.4

307.7

2568

9302

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

163.8

307.7

161

AA1AD

NOMESCO Finland

CT of head and brain

5.2

307.7

4729

15503

N05BA01

ATC

diazepam; systemic, rectal

3.5

307.7

1900

6333

N03AF02

ATC

oxcarbazepine; oral

186.5

307.7

3970

371

L01AX03

ATC

temozolomide; systemic

49.0

307.7

510

110

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

307.7

3394

N03AX14

ATC

levetiracetam; systemic

251.6

307.7

3633

237

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

11101.4

307.7

1003

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

5.3

307.7

1547

3362

R56.8

ICD-10 Finland

Other and unspecified convulsions

44.9

307.7

3588

1287

N88

ICPC

Epilepsy

828.5

307.7

620

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.8

307.7

1616

4900

N03AF01

ATC

carbamazepine; oral, rectal

18.8

307.7

2183

1493

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

30.6

307.7

265

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

91.6

307.7

241

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

16384.0

307.7

3350

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

8.9

307.7

840

1029

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

3473.2

307.7

345

G40

ICD-10 Finland

Epilepsy

1119.2

307.7

910

N03AX09

ATC

lamotrigine; oral

8.5

307.7

1237

1645

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

41.7

307.7

396

N03AX18

ATC

lacosamide; systemic

1121.4

307.7

1089

XA800

NOMESCO Finland

Neuropsychological investigation

7.9

307.7

1143

1623

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

307.7

1515

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5197.2

307.7

957

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

8.0

307.7

2227

3536

N03AX11

ATC

topiramate; oral

7.9

307.7

526

698

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

307.7

3852

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

307.7

1050

N03AG01

ATC

valproic acid; systemic, rectal

26.3

307.7

3119

1751

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3099.6

307.7

602

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

10.6

307.7

568

566

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

17.6

307.7

449

267

ZXC95

NOMESCO Finland

Use of surgical navigator

11.7

307.7

359

317

N03AX15

ATC

zonisamide; oral

60.9

307.7

197

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

307.2

1194

3776

H02AB02

ATC

dexamethasone; systemic

3.1

307.1

1450

5164

G41.0

ICD-10 Finland

Grand mal status epilepticus

150.3

296.8

148

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

13.1

288.2

277

217

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

8.8

286.7

367

434

R55

ICD-10 Finland

Syncope and collapse

3.0

284.3

1479

5551

K90

ICPC

Stroke/cerebrovascular accident

5.7

279.5

542

1002

T90.5

ICD-10 Finland

Sequelae of intracranial injury

10.2

266.3

302

304

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

+∞

263.8

252

Z2445

NOMESCO Finland

Psychologist

4.4

260.9

694

1676

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

10.1

257.3

294

299

G41.2

ICD-10 Finland

Complex partial status epilepticus

89.2

251.3

132

R41.0

ICD-10 Finland

Disorientation, unspecified

5.1

250.5

545

1116

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

15.0

250.3

222

151

N03AE01

ATC

clonazepam; systemic

3.8

247.2

817

2309

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

106.4

244.8

126

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

6.0

241.8

438

758

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

85.1

238.5

126

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

1177.7

236.3

230

7803A

ICD-9 Finland

General symptoms, Convulsions

11.7

231.9

239

209

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.7

231.8

442

803

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

82.4

229.9

122

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

14.2

226.1

207

149

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

4.7

225.3

537

1186

N07

ICPC

Convulsion/seizure

39.1

220.9

135

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

74.7

219.3

118

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

31.3

218.2

142

H53.4

ICD-10 Finland

Visual field defects

5.9

211.3

387

676

N03AX22

ATC

perampanel; oral

1952.8

207.9

201

R47.0

ICD-10 Finland

Dysphasia and aphasia

9.8

206.3

240

250

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

4.1

204.1

593

1525

R4150

NOMESCO Finland

Neuropsychological rehabilitation

12.0

202.7

205

174

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

199.2

1823

8882

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.9

196.2

309

463

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

193.0

1126

4441

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.5

192.6

319

504

TAB00

NOMESCO Finland

Lumbar puncture

3.7

185.4

622

1768

130

Kela drug reimbursment

Malignant tumour

2.7

182.8

1066

4197

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

22.7

181.0

132

N18

ICPC

Paralysis/weakness

5.6

179.9

347

636

34532

ICD-8 Finland

Epilepsy, Partialis (focalis) generalisata

+∞

178.7

171

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

7.2

178.6

269

384

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

177.6

3109

19192

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

10.6

177.1

195

188

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

6.4

174.9

292

465

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

174.5

167

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

9.2

172.4

211

235

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

166.1

2583

15258

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

15.3

165.7

145

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.8

165.4

939

3638

S06.3

ICD-10 Finland

Focal brain injury

6.9

165.2

258

383

3454B

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]

+∞

165.0

158

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

33.2

164.2

105

34530

ICD-8 Finland

Epilepsy, Psychomotorica

+∞

164.0

157

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

9.3

163.2

198

218

ZXC40

NOMESCO Finland

Use of ultrasound

10.3

159.6

179

177

A28

ICPC

Limited function/disability NOS

2.1

159.3

1774

9271

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.4

159.1

320

609

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

21.7

156.4

116

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

9.5

154.3

184

198

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

8.0

153.8

209

265

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

9.1

153.5

189

212

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

13.5

150.9

142

107

R4120

NOMESCO Finland

Occupational therapy

2.9

150.2

779

2873

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

148.9

755

2750

N05AX08

ATC

risperidone; systemic

2.6

148.3

962

3976

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

+∞

145.1

139

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

14.6

141.5

127

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

46.5

141.4

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

7.0

140.1

216

316

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.7

136.3

258

464

WX892

NOMESCO Finland

Monitored bed care

2.6

135.8

867

3550

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.5

135.0

493

1477

G40.0

ICD-10 Finland

Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

1333.0

134.7

131

3459X

ICD-9 Finland

Epilepsy, unspecified

+∞

133.6

128

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

132.4

826

3343

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

24.7

131.9

AAK00

NOMESCO Finland

Cranioplasty

41.9

131.4

S06.0

ICD-10 Finland

Concussion

2.3

130.6

1174

5600

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.6

129.5

454

1324

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

49.7

127.8

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

36.2

126.6

N06AB04

ATC

citalopram; systemic

1.9

124.2

1947

11370

R51.80

ICD-10 Finland

Headache

2.0

122.5

1514

8149

F05.9

ICD-10 Finland

Delirium, unspecified

4.4

119.2

305

710

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

119.0

1610

8937

R53

ICD-10 Finland

Malaise and fatigue

1.8

118.6

2285

14203

WX882

NOMESCO Finland

High dependency care

3.5

118.3

428

1273

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.2

117.3

495

1620

N05AH04

ATC

quetiapine; oral

1.9

115.9

1688

9597

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

200.8

114.8

119

K91

ICPC

Cerebrovascular disease

5.6

114.7

221

404

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

113.7

109

AAF00

NOMESCO Finland

Ventriculostomy

9.6

113.6

134

142

ZX050

NOMESCO Finland

Stereotactic radiotherapy

7.4

109.8

160

220

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

109.2

1229

6372

N03AG04

ATC

vigabatrin; oral

+∞

108.5

104

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

11.7

108.3

111

L28

ICPC

Limited function/disability (L)

1.9

108.3

1655

9539

N03AF04

ATC

eslicarbazepine; oral

+∞

107.5

103

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.6

107.3

661

2651

W19

ICD-10 Finland

Unspecified fall

2.2

107.0

1026

5001

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

106.9

4087

30332

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

106.4

325

862

Z51.5

ICD-10 Finland

Palliative care

2.4

105.7

814

3620

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

5.4

103.9

205

383

G41.8

ICD-10 Finland

Other status epilepticus

43.8

102.4

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

102.4

757

3305

SPAT1229

SPAT

Assessment of need for aid

2.3

99.8

789

3546

N05BA04

ATC

oxazepam; oral

1.7

99.8

2314

15050

N74

ICPC

Malignant neoplasm nervous system

36.7

99.6

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

16.3

99.3

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

6.5

99.3

164

258

S06.2

ICD-10 Finland

Diffuse brain injury

6.1

98.9

172

285

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

6.6

97.8

159

246

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.4

97.7

371

1137

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

7.5

97.6

140

189

R40.2

ICD-10 Finland

Coma, unspecified

6.8

96.7

152

227

A06AD11

ATC

lactulose; oral

1.9

96.0

1411

8001

WX872

NOMESCO Finland

Intensive care

2.7

95.2

552

2145

R42

ICD-10 Finland

Dizziness and giddiness

1.7

94.6

2042

12994

WX730

NOMESCO Finland

Conventional respirator

4.6

93.4

223

491

G91.0

ICD-10 Finland

Communicating hydrocephalus

9.3

93.0

112

122

SPAT1216

SPAT

Assessment of functional ability

1.9

92.8

1431

8234

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.4

90.9

674

2942

N28

ICPC

Limited function/disability (N)

4.4

89.8

227

523

R4130

NOMESCO Finland

Speech therapy

3.5

89.6

318

933

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

187.8

89.4

Z2446

NOMESCO Finland

Social worker

2.3

89.3

713

3213

A04AA02

ATC

granisetron; systemic, transdermal

2.5

88.8

613

2589

N05AH03

ATC

olanzapine; systemic

2.5

88.8

619

2627

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

88.7

1272

7140

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

51.3

88.5

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

88.4

1985

12734

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

87.0

1873

11873

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.3

86.5

176

338

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

50.2

86.4

181

Kela drug reimbursment

Retigabine and vigabatrin

+∞

85.5

S01.0

ICD-10 Finland

Open wound of scalp

2.2

84.9

795

3824

AA5PD

NOMESCO Finland

CT examination of brain pefusion

6.3

84.8

144

233

N02AA05

ATC

oxycodone; systemic

1.8

83.9

1565

9515

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

+∞

83.4

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

83.4

1385

8132

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

83.2

357

1177

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

10.5

83.0

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

83.0

1452

8660

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

82.9

701

3234

N19

ICPC

Speech disorder

4.2

82.9

223

539

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

81.6

986

5213

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

81.3

581

2491

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

27.6

81.1

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

80.8

470

1827

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.0

80.7

229

576

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

+∞

80.3

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

80.1

1045

5673

N76

ICPC

Neoplasm nervous system unspecified

26.3

79.7

XX3DW

NOMESCO Finland

Time consuming IT work

2.0

79.4

974

5175

N29

ICPC

Neurological sympt/complt other

3.8

78.2

246

666

R56.0

ICD-10 Finland

Febrile convulsions

8.6

76.8

115

A86

ICD-10 Finland

Unspecified viral encephalitis

8.7

76.5

113

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

10.3

76.4

PA6AD

NOMESCO Finland

CT of neck arteries

3.1

76.2

319

1037

34539

ICD-8 Finland

Epilepsy, Partialis (focalis) NUD

+∞

75.1

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

8.0

74.8

101

127

XCK00

NOMESCO Finland

Perimetry

2.3

74.5

612

2786

SPAT1234

SPAT

Support of social functional capacity

2.4

74.4

529

2262

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

194.0

74.2

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

74.0

770

3850

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

24.9

73.8

WF002

NOMESCO Finland

Radical radiotherapy

2.4

73.7

538

2327

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

73.4

486

2011

ZXD05

NOMESCO Finland

Urgent procedure

1.6

73.1

2643

18920

PA2AD

NOMESCO Finland

CT angiography of brain

6.1

72.4

126

209

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

8.7

71.4

104

N05CF01

ATC

zopiclone; oral

1.5

70.9

2704

19562

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

70.6

1176

6886

N06AX11

ATC

mirtazapine; oral

1.5

70.2

2816

20584

H47.2

ICD-10 Finland

Optic atrophy

8.5

69.5

105

R1260

NOMESCO Finland

Evaluation of communicative skills

3.9

68.8

207

543

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

14.6

68.1

C03CA01

ATC

furosemide; systemic

1.5

67.4

2556

18429

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

66.7

657

3215

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

9.6

66.5

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.9

66.0

146

302

SPAT1254

SPAT

Administration of medicine

1.7

65.8

1365

8499

M03BX01

ATC

baclofen; systemic

3.7

64.9

211

584

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

11.2

64.7

N05AA02

ATC

levomepromazine; systemic

2.6

64.6

387

1525

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.9

64.6

195

513

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

+∞

63.6

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

16.6

63.3

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

62.5

1648

10903

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.2

62.4

257

827

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.8

61.8

190

506

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.7

61.3

144

313

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

8.1

61.3

102

Z3231

NOMESCO Finland

Registered nurse

1.5

61.1

2378

17172

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

60.4

1515

9892

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

9.2

60.3

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

4.9

60.1

133

275

P20

ICPC

Memory disturbance

1.7

60.1

1128

6817

AAA10

NOMESCO Finland

Biopsy through craniotomy

24.8

59.5

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

59.1

473

2127

F80.1

ICD-10 Finland

Expressive language disorder

4.5

58.5

143

321

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

10.6

58.5

N05CD07

ATC

temazepam; oral

1.8

58.3

980

5734

N06AB10

ATC

escitalopram; oral

1.6

58.2

1655

11129

S06.4

ICD-10 Finland

Epidural haemorrhage

14.5

57.8

3454X

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]

+∞

57.3

AAJ20

NOMESCO Finland

Excision of epileptic focus

+∞

57.3

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

13.7

57.0

N99

ICPC

Neurological disease other

4.2

56.6

152

367

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

4.5

56.2

139

315

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.8

55.8

170

450

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

55.3

456

2076

34533

ICD-8 Finland

Epilepsy, Partialis (focalis) alia

+∞

55.2

R41.3

ICD-10 Finland

Other amnesia

2.8

55.1

292

1081

SPAT1301

SPAT

No procedures

1.5

54.9

2631

19734

R46.8

ICD-10 Finland

Other symptoms and signs involving appearance and behaviour

16.5

54.7

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.5

54.6

344

1389

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

15.1

54.5

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

17.7

54.1

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

54.0

1253

8001

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

187.7

54.0

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

16.7

53.9

ZXM40

NOMESCO Finland

Use of fluorescent substance

16.7

53.9

B01AC04

ATC

clopidogrel; oral

1.6

53.2

1358

8879

R50.9

ICD-10 Finland

Fever, unspecified

1.6

53.0

1320

8579

Z3226

NOMESCO Finland

Physiotherapist

1.6

52.8

1536

10356

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

97.3

52.8

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

19.6

52.8

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

52.6

692

3746

R11

ICD-10 Finland

Nausea and vomiting

1.9

52.4

768

4305

R1250

NOMESCO Finland

Evaluation of functional capability

3.0

52.3

232

780

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

11.8

52.3

3455A

ICD-9 Finland

Epilepsy, Partial epilepsy, without mention of impairment of consciousness

+∞

52.1

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.2

52.1

205

642

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

51.6

1124

7057

D32.03

ICD-10 Finland

Benign meningioma in ventricles

16.6

51.3

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

82.0

50.9

G91.1

ICD-10 Finland

Obstructive hydrocephalus

7.5

50.8

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

256.7

50.1

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.5

49.7

311

1251

N02BE01

ATC

paracetamol; systemic, rectal

1.5

49.7

7628

69818

R4110

NOMESCO Finland

Physiotherapy

1.5

49.6

2238

16528

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

49.5

1839

13061

N05AD01

ATC

haloperidol; systemic

2.6

49.5

295

1159

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

14.1

49.3

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

3.9

49.3

145

375

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

8.4

48.8

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

48.5

2131

15646

B01AA03

ATC

warfarin; systemic

1.5

48.4

1609

11156

A02BC02

ATC

pantoprazole; systemic

1.4

48.4

5565

48205

G72.8

ICD-10 Finland

Other specified myopathies

3.5

48.1

169

493

H02AB09

ATC

hydrocortisone; systemic

2.7

48.0

257

957

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.1

48.0

207

685

RS222, ,

NOMESCO Finland

3.8

47.6

147

393

R25.2

ICD-10 Finland

Cramp and spasm

2.8

46.9

235

845

G40.59

ICD-10 Finland

Other special epileptic syndromes

+∞

46.9

N03AX25

ATC

cenobamate; oral

+∞

46.9

I63.8

ICD-10 Finland

Other cerebral infarction

4.4

46.8

119

276

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

9.5

46.8

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

46.5

410

1917

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

85.5

45.8

ZXY02

NOMESCO Finland

Neuropsychologist

5.9

45.8

140

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.3

45.7

173

529

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

7.0

45.6

N03AX12

ATC

[U] gabapentin; oral

1.6

45.5

1282

8555

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

17.7

45.4

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.1

45.4

195

644

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

6.4

44.7

117

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

44.6

392

1831

A04AA01

ATC

ondansetron; systemic, rectal

1.9

44.4

645

3599

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

44.2

760

4461

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.4

44.2

313

1334

P85

ICPC

Mental retardation

9.0

44.2

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.4

44.1

321

1384

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

43.8

2869

22562

A04

ICPC

Weakness/tiredness general

1.6

43.5

1228

8190

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

43.0

531

2809

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

10.3

43.0

R25.1

ICD-10 Finland

Tremor, unspecified

2.5

43.0

285

1178

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

4.3

42.9

111

261

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

10.5

42.8

G40.80

ICD-10 Finland

Epilepsy with continuous EEG spike-waves during slow wave sleep

+∞

42.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

42.7

1574

11124

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.9

42.6

207

732

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

42.3

520

2747

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

7.4

42.3

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

14.8

41.6

9400/3-C71.9

ICD-O-3

Astrocytoma, NOS, of brain, NOS

409.3

41.1

SPAT1240

SPAT

Therapeutic discussion

1.7

41.1

823

5038

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.2

40.9

108

258

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.1

40.8

114

284

F83

ICD-10 Finland

Mixed specific developmental disorders

4.6

40.7

206

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.6

40.5

134

376

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

40.3

2478

19226

G81.1

ICD-10 Finland

Spastic hemiplegia

11.4

39.5

2161

FHL

Neck ligation, big brain

7.9

39.5

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

39.3

525

2851

ZXD35

NOMESCO Finland

Usual procedure

2.3

39.2

293

1278

2152

FHL

Extraction, big brain

12.2

39.2

OAB43, ,

SPAT

0.6

39.2

1066

15599

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

39.1

359

1705

9400/3-C71.1

ICD-O-3

Astrocytoma, NOS, of frontal lobe

389.1

39.1

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

10.0

38.9

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.0

38.8

177

605

C71.31

ICD-10 Finland

Malignant tumor of the parietal lobe grand II glioma

137.2

38.7

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

38.6

206

766

G40.50

ICD-10 Finland

Epilepsia partialis continua [Kozhevnikof]

+∞

38.6

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

37.8

1105

7414

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

6.1

37.7

107

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

6.3

37.5

101

AAJ99

NOMESCO Finland

Other operation for epilepsy

+∞

37.5

GBB00

NOMESCO Finland

Tracheostomy

3.6

37.3

121

335

B01AC07

ATC

dipyridamole; systemic

2.1

37.3

387

1925

N06AX16

ATC

venlafaxine; oral

1.6

36.9

1045

6961

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

8.7

36.6

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

36.5

1146

16311

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

13.6

36.5

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

54.0

36.3

N05AF03

ATC

chlorprothixene; systemic

2.6

36.2

216

850

F03

ICD-10 Finland

Unspecified dementia

2.1

36.2

349

1690

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

35.6

339

1633

34598

ICD-8 Finland

Epilepsy, Alia definita

+∞

35.4

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

35.4

700

4265

F05.8

ICD-10 Finland

Other delirium

4.4

35.4

205

H53.2

ICD-10 Finland

Diplopia

2.3

35.2

275

1223

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

12.1

35.0

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

35.0

341

1658

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

4.4

34.9

203

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.0

34.8

246

3069, ,

Kela drug reimbursment

+∞

34.4

1541, ,

Kela drug reimbursment

+∞

34.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

34.4

2160

16739

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

34.3

323

1549

N03AX16

ATC

[U] pregabalin

1.4

34.1

1748

13084

N03AG06

ATC

tiagabine; oral

338.4

33.9

WYA20

NOMESCO Finland

Home visit

2.8

33.6

170

615

G40.8

ICD-10 Finland

Other epilepsy

+∞

33.3

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.0

33.3

145

483

S22.3

ICD-10 Finland

Fracture of rib

1.8

33.2

563

3286

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

55.9

33.2

SPAT1053

SPAT

Memory test

1.5

33.2

1080

7405

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

6.6

33.1

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.0

33.1

373

1912

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

7.0

33.0

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.9

32.9

252

Z75.5

ICD-10 Finland

Holiday relief care

4.0

32.7

231

E87.6

ICD-10 Finland

Hypokalaemia

2.2

32.7

272

1243

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

32.6

309

1486

N05AX12

ATC

aripiprazole; systemic

2.1

32.5

310

1494

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

32.3

872

5734

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.1

32.3

312

1511

A29

ICPC

General symptom/complaint other

1.5

32.3

973

6560

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.9

32.3

151

524

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

13.0

32.2

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

32.1

883

5832

C71.32

ICD-10 Finland

Malignant tumor of parietal lobe grade III glioma

318.1

31.9

F10.24

ICD-10 Finland

Alcohol depence active use

3.0

31.8

140

470

9450/3-C71.1

ICD-O-3

Oligodendroglioma, NOS, of frontal lobe

165.5

31.7

N06AB06

ATC

sertraline; oral

1.6

31.6

842

5519

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3.8

31.5

255

G93.0

ICD-10 Finland

Cerebral cysts

5.7

31.5

102

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.8

31.4

150

S02.11

ICD-10 Finland

Fracture of base of skull, open

6.6

31.4

C08CA01

ATC

amlodipine; oral

1.3

31.4

2889

23651

N30.0

ICD-10 Finland

Acute cystitis

1.5

31.3

1179

8325

SPAT1252

SPAT

Overall medication plan or its review

1.8

31.2

525

3058

ZY010

NOMESCO Finland

Hospital outpatient

1.9

31.1

416

2258

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

31.1

578

3460

N07BB01

ATC

disulfiram; oral

2.0

31.1

331

1662

AA9CW, ,

NOMESCO Finland

10.0

30.9

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

9.3

30.9

G45.4

ICD-10 Finland

Transient global amnesia

2.5

30.7

193

779

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

8.9

30.6

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

30.6

302

1476

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

6.0

30.5

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.3

30.3

224

973

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

30.3

2843

23311

N05AB03

ATC

perphenazine; systemic, rectal

2.2

30.2

273

1289

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

+∞

30.2

AAJ15

NOMESCO Finland

Hippocampectomy

+∞

30.2

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

5.8

30.1

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

29.9

416

2286

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

32.6

29.9

Y86

ICD-10 Finland

Sequelae of other accidents

5.7

29.8

I61

ICD-10 Finland

Intracerebral haemorrhage

10.3

29.7

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

29.7

1035

7189

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

29.6

342

1769

OAA67, ,

SPAT

0.6

29.5

403

7032

JN4BD

NOMESCO Finland

Extensive body CT

1.6

29.5

781

5111

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

3.0

29.5

134

458

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

29.5

1432

10592

S00.0

ICD-10 Finland

Superficial injury of scalp

2.4

29.1

204

867

B01AB05

ATC

enoxaparin; parenteral

1.3

29.0

2329

18651

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

29.0

5806

52377

Q85.1

ICD-10 Finland

Tuberous sclerosis

66.1

28.9

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.4

28.8

161

N05AH02

ATC

clozapine; systemic

2.7

28.8

153

569

N80

ICPC

Head injury other

2.5

28.6

184

751

Q04.8

ICD-10 Finland

Other specified congenital malformations of brain

43.9

28.6

WX704

NOMESCO Finland

Intubation

1.7

28.6

607

3763

N04AA02

ATC

biperiden; systemic

2.7

28.5

154

578

G41.1

ICD-10 Finland

Petit mal status epilepticus

39.0

28.0

-, ,

ICD-10 Finland

2.4

28.0

191

802

H03AA01

ATC

levothyroxine sodium; systemic

1.4

27.8

1633

12461

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

27.8

2180

17386

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

10.7

27.7

F06.32

ICD-10 Finland

Organic depression

7.5

27.5

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.1

27.5

116

380

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.8

27.5

139

504

R40.0

ICD-10 Finland

Somnolence

5.5

27.2

JN4AD

NOMESCO Finland

Body CT examination

1.6

27.0

744

4909

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

6.2

27.0

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

26.9

210

935

F44.5

ICD-10 Finland

Dissociative convulsions

75.3

26.7

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.5

26.7

168

679

U04

ICPC

Incontinence urine

1.8

26.7

396

2220

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

7.5

26.7

C71.01

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade II glioma

140.4

26.6

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

5.4

26.6

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

26.6

541

3318

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

24.7

26.5

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

26.3

708

4647

Y0209

ICD-8 Finland

Examination of the nervous system and sensory organs, Nervous system

4.2

26.2

165

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

10.4

26.2

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

9.4

26.1

ZX095

NOMESCO Finland

Combined chemoradiotherapy

4.1

26.1

174

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

26.1

407

2318

9450/3-C71.9

ICD-O-3

Oligodendroglioma, NOS, of brain, NOS

+∞

26.0

S06.9

ICD-10 Finland

Intracranial injury, unspecified

3.9

26.0

192

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.4

25.9

281

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

25.9

531

3263

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.0

25.7

269

1343

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.3

25.6

188

816

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.9

25.4

116

398

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.0

25.1

110

369

A07

ICPC

Coma

5.0

25.1

106

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

25.0

524

3236

F07.2

ICD-10 Finland

Postconcussional syndrome

8.9

25.0

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

25.0

404

2324

G40.01

ICD-10 Finland

Pediatric epilepsy with occipital EEG paroxysms

+∞

25.0

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

6.7

25.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

25.0

450

2670

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

24.8

772

5230

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

24.6

370

2085

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

7.2

24.5

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

42.9

24.5

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.8

24.4

126

462

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

24.3

445

2653

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

4.0

24.2

171

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.0

24.2

171

C02AC05

ATC

moxonidine; oral

1.8

24.1

343

1899

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.4

24.1

162

676

P29

ICPC

Psychological sympt/compl other

1.7

24.1

507

3136

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

56.1

24.0

RL140, ,

NOMESCO Finland

6.3

23.9

RS122, ,

NOMESCO Finland

5.6

23.9

R5110, ,

SPAT

1.7

23.9

464

2810

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

6.4

23.8

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

23.8

808

5570

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

22.7

23.8

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

20.7

23.8

Z00.0

ICD-10 Finland

General medical examination

1.4

23.8

1455

11143

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

23.7

383

2205

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.5

23.6

229

D21

ICPC

Swallowing problem

2.7

23.6

130

493

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.4

23.5

249

AAF15

NOMESCO Finland

Ventriculoatrial shunt

6.3

23.5

AAK80

NOMESCO Finland

Partial excision of skull cap

19.5

23.4

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

23.4

112

395

P72

ICPC

Schizophrenia

2.5

23.2

150

615

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

5.0

23.2

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

23.1

857

6015

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.3

23.1

272

N06AX22

ATC

agomelatine; oral

2.3

23.1

172

752

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.6

23.0

132

511

X58

ICD-10 Finland

Exposure to other specified factors

1.4

23.0

1055

7700

Z50.5

ICD-10 Finland

Speech therapy

2.6

22.9

137

541

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

22.9

389

2270

E86

ICD-10 Finland

Volume depletion

2.2

22.9

197

914

C10AA01

ATC

simvastatin; oral

1.3

22.9

3096

26362

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

22.9

645

4276

C07AB07

ATC

bisoprolol; oral

1.3

22.8

3679

31958

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

4.2

22.7

144

N06AX03

ATC

mianserin; oral

1.8

22.6

340

1916

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.9

22.5

103

354

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.8

22.5

325

1808

ZXA05

NOMESCO Finland

Left side

1.3

22.5

1799

14322

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

22.4

651

4342

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.4

22.4

237

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

22.4

165

718

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

22.4

297

1610

R60.0

ICD-10 Finland

Localized oedema

1.4

22.3

885

6289

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.4

22.3

243

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.9

22.2

101

346

N05AD03

ATC

melperone; systemic

2.8

22.2

108

384

S18

ICPC

Laceration/cut

1.2

22.2

3482

30122

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.3

22.1

244

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.2

22.1

279

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.2

22.1

274

S72.0

ICD-10 Finland

Fracture of neck of femur

1.9

22.1

300

1637

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

22.0

980

7113

J01EA01

ATC

trimethoprim; systemic

1.3

22.0

1823

14579

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

4.3

21.9

127

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

62.6

21.8

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

21.7

388

2298

J01DB01

ATC

cefalexin; oral

1.3

21.7

6901

64481

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

7.7

21.6

RS221, ,

NOMESCO Finland

2.6

21.5

127

499

G93.4

ICD-10 Finland

Encephalopathy, unspecified

6.1

21.5

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

1.9

21.5

286

1552

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

21.4

201

965

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

21.4

147

620

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

3.7

21.3

178

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.7

21.3

110

404

P15

ICPC

Chronic alcohol abuse

2.0

21.3

218

1081

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

3.8

21.2

174

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

7.5

21.2

RT150, ,

NOMESCO Finland

4.5

21.2

114

C07AA05

ATC

propranolol; systemic

1.3

21.1

1407

10899

R33

ICD-10 Finland

Retention of urine

1.5

21.1

598

3967

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.3

21.0

158

694

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

20.9

238

1226

34500

ICD-8 Finland

Epilepsy, """"Petit mal""""

+∞

20.8

AAJ10

NOMESCO Finland

Lobectomy for epilepsy

+∞

20.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

20.8

2301

19078

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

24.2

20.8

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

20.8

497

3172

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.2

20.8

166

748

113

Kela drug reimbursment

Anxiety disorders associated with mental retardation

7.1

20.7

G44.2

ICD-10 Finland

Tension-type headache

1.4

20.7

927

6730

P99

ICPC

Psychological disorders other

2.0

20.7

211

1045

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

4.6

20.7

108

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

20.7

500

3199

OAB48, ,

SPAT

0.6

20.7

440

6879

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

6.2

20.6

AAU00

NOMESCO Finland

Removal of implant or external fixation device from skull

110.2

20.6

XX3XW, ,

NOMESCO Finland

3.7

20.5

169

M01AH05

ATC

etoricoxib; oral

0.8

20.4

3698

41701

ZXA00

NOMESCO Finland

Right side

1.3

20.4

1915

15550

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

7.8

20.4

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

3.9

20.4

152

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

20.3

210

1045

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

22.4

20.3

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

20.2

291

1620

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

20.1

774

5465

F06.7

ICD-10 Finland

Mild cognitive disorder

2.0

20.1

214

1078

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

19.9

454

2865

N06DA03

ATC

rivastigmine; oral, transdermal

1.8

19.9

307

1744

N05BA02

ATC

chlordiazepoxide; systemic

2.2

19.9

173

807

C71.39

ICD-10 Finland

Malignant tumor of parietal lobe other or unspecified histology

57.6

19.9

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

19.9

442

2772

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.2

19.8

158

711

AAA35

NOMESCO Finland

Insertion of subdural electrodes

+∞

19.8

34531

ICD-8 Finland

Epilepsy, Patrialis (focalis) Jackson

+∞

19.8

9401/3-C71.9

ICD-O-3

Astrocytoma, anaplastic, NOS, of brain, NOS

+∞

19.8

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.7

19.8

104

386

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

19.8

381

2303

SPAT1172

SPAT

Guidance concerning hydration

2.1

19.7

176

829

F06.0

ICD-10 Finland

Organic hallucinosis

6.2

19.7

96610

ICD-8 Finland

Adverse effect of anticonvulsants, Hydantoin derivatives

73.6

19.7

9440/3-C71.3

ICD-O-3

Glioblastoma, NOS, of parietal lobe

73.6

19.7

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

19.6

461

2930

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

4.8

19.6

AA1AA

NOMESCO Finland

Head X-ray examination

3.1

19.6

253

EBA00

NOMESCO Finland

Extraction of tooth

1.2

19.6

2707

23006

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

7.7

19.5

SPAT1167

SPAT

Insertion of urinary catheter

1.9

19.5

241

1278

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.1

19.4

182

874

WZC30

NOMESCO Finland

Teaching

1.4

19.4

1116

8445

RS211, ,

NOMESCO Finland

4.3

19.4

114

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

19.4

404

2493

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.8

19.3

335

N05CD02

ATC

nitrazepam; oral

2.4

19.3

126

520

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

19.3

461

2943

R56

ICD-10 Finland

Convulsions, not elsewhere classified

31.3

19.2

G04.8

ICD-10 Finland

Other encephalitis, myelitis and encephalomyelitis

15.5

19.2

K59.0

ICD-10 Finland

Constipation

1.6

19.2

411

2553

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

19.1

291

1646

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

16.7

19.1

SPAT1260

SPAT

Consultation of another employee

1.3

19.0

1269

9825

Z29

ICPC

Social problem NOS

2.2

19.0

163

757

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.8

18.9

291

1651

G43.3

ICD-10 Finland

Complicated migraine

2.5

18.9

117

471

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.1

18.8

125

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

18.8

1877

15342

9451/3-C71.1

ICD-O-3

Oligodendroglioma, anaplastic, NOS, of frontal lobe

+∞

18.7

C71.82

ICD-10 Finland

Overall malignant tumor of the brain grade III glioma

+∞

18.7

SPAT1263

SPAT

Sampling

1.2

18.7

3199

27787

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

27.8

18.7

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

2.9

18.6

314

S02.10

ICD-10 Finland

Fracture of base of skull, closed

4.4

18.6

105

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

18.6

479

3112

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

18.5

321

1885

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

18.4

652

4530

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.1

18.3

164

774

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

18.3

504

3322

A46

ICD-10 Finland

Erysipelas

1.4

18.3

1045

7895

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.1

18.2

163

769

XF404

NOMESCO Finland

Ambulatory ECG

1.5

18.2

630

4356

5AB01, ,

NOMESCO Finland

6.8

18.2

OAA80, ,

SPAT

0.5

18.2

227

4078

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

17.5

18.2

RS313, ,

NOMESCO Finland

5.2

18.1

R13

ICD-10 Finland

Dysphagia

1.6

18.1

480

3138

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

18.0

376

ZY000

NOMESCO Finland

Hospital inpatient

2.6

18.0

100

382

RS121, ,

NOMESCO Finland

3.4

18.0

190

N06AB03

ATC

fluoxetine; oral

1.4

18.0

824

6004

N03AA02

ATC

phenobarbital; systemic

15.3

17.9

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

15.3

17.9

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

17.9

950

7094

N05BA12

ATC

alprazolam; oral

1.5

17.8

672

4726

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

4.3

17.7

105

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.2

17.7

155

725

AA5FK

NOMESCO Finland

Functional assessment (fMRI) of brain

+∞

17.7

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

22.8

17.7

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

17.7

229

1233

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.6

17.6

421

2687

WF004

NOMESCO Finland

Palliative radiotherapy

2.1

17.6

156

734

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

17.6

226

1214

J01CA08

ATC

pivmecillinam; oral

1.2

17.6

2657

22746

N27

ICPC

Fear of neurological disease other

2.3

17.4

126

545

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

5.9

17.4

G83.8

ICD-10 Finland

Other specified paralytic syndromes

13.1

17.4

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

17.3

473

3113

G30.0

ICD-10 Finland

Alzheimer disease with early onset

3.0

17.3

251

M05BA04

ATC

alendronic acid; oral

1.5

17.3

558

3806

9537/0-C70.0

ICD-O-3

Transitional meningioma of cerebral meninges

20.9

17.3

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

17.2

2825

24382

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

17.2

417

2672

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.2

17.1

140

638

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.0

17.1

121

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

12.5

17.1

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

3.0

17.0

254

G93.6

ICD-10 Finland

Cerebral oedema

25.6

16.9

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.2

16.9

135

610

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

3.5

16.8

164

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.7

16.8

321

Z08

ICPC

Social welfare problem

2.5

16.8

101

402

Z60.8

ICD-10 Finland

Other problems related to social environment

4.7

16.8

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.8

16.7

305

3458X

ICD-9 Finland

Epilepsy, Other forms of epilepsy

+∞

16.7

3431A

ICD-9 Finland

Infantile cerebral palsy, Hemiplegic

35.1

16.6

K08.3

ICD-10 Finland

Retained dental root

1.5

16.6

526

3572

RS340, ,

NOMESCO Finland

5.0

16.6

XX1FW

NOMESCO Finland

Written report from MRI examination performed elsewhere

15.0

16.6

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

5.8

16.6

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

16.5

2922

25383

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.2

16.5

139

641

C71

ICD-10 Finland

Malignant neoplasm of brain

170.2

16.5

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

27.5

16.5

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

27.5

16.5

AAD00

NOMESCO Finland

Evacuation of epidural haematoma

20.0

16.4

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

20.0

16.4

A99

ICPC

Disease/condition unspecnature/site

1.4

16.4

639

4522

N06DX01

ATC

memantine; oral

1.5

16.4

505

3412

N05AF05

ATC

zuclopenthixol; systemic

3.0

16.3

228

P03

ICPC

Feeling depressed

1.4

16.3

656

4670

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

16.2

822

10917

ZX120

NOMESCO Finland

Intravenous

1.4

16.2

657

4683

R63.1

ICD-10 Finland

Polydipsia

5.0

16.2

R2110

NOMESCO Finland

Giving the first information

1.5

16.1

435

2855

N05AN01

ATC

lithium; oral

2.0

16.1

163

807

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

4.4

16.1

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

16.0

354

2218

I63

ICD-10 Finland

Cerebral infarction

3.0

16.0

241

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

16.0

539

3707

C09AA05

ATC

ramipril; oral

1.3

16.0

1763

14548

N75

ICPC

Benign neoplasm nervous system

18.5

16.0

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

15.9

367

2322

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.1

15.9

157

770

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

15.9

462

3081

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.9

15.9

192

1011

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.2

15.8

125

563

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

15.7

1291

10264

R51

ICD-10 Finland

Headache

1.6

15.7

371

2361

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

33.4

15.7

S42.0

ICD-10 Finland

Fracture of clavicle

1.9

15.7

204

1101

N06AG02

ATC

moclobemide; oral

1.7

15.7

281

1668

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.3

15.7

117

514

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

15.6

412

2690

F61.0

ICD-10 Finland

Mixed personality disorders

2.3

15.6

116

508

9401/3-C71.2

ICD-O-3

Astrocytoma, anaplastic, NOS, of temporal lobe

+∞

15.6

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.5

15.6

153

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

17.2

15.6

N06AX21

ATC

duloxetine; oral

1.4

15.6

760

5594

K92.0

ICD-10 Finland

Haematemesis

2.0

15.6

177

914

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

85.2

15.6

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.0

15.5

155

764

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

3.3

15.5

168

J01DA01

ATC

[U] cefalexin

1.2

15.5

4753

43390

SPAT1153

SPAT

Removal of sutures

1.2

15.5

2244

19075

AAA40

NOMESCO Finland

Insertion of intracerebral electrodes

160.2

15.5

N05AB01

ATC

dixyrazine; systemic

2.6

15.5

341

W06

ICD-10 Finland

Fall involving bed

3.0

15.4

225

S06.8

ICD-10 Finland

Other intracranial injuries

5.7

15.4

R62.0

ICD-10 Finland

Delayed milestone

3.1

15.3

210

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

28.6

15.2

RT490, ,

NOMESCO Finland

13.0

15.1

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.6

15.1

316

NC2AA

NOMESCO Finland

Forearm X-ray examination

2.3

15.0

110

479

34300

ICD-8 Finland

Cerebral spastic infantile paralysis, Hemiplegia spastica

45.0

15.0

G80.8

ICD-10 Finland

Other cerebral palsy

45.0

15.0

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.7

15.0

300

N05BE01

ATC

buspirone; oral

1.9

15.0

196

1060

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

14.9

1665

13743

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

6.5

14.9

A98

ICPC

Health maint/preventive medicine

0.8

14.9

7966

82199

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

14.8

863

6531

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

6.8

14.8

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.5

14.8

384

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

14.8

384

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.1

14.8

145

710

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

14.8

767

5702

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.8

14.8

247

V03AA01, ,

ATC

2.3

14.7

110

484

SPAT1101

SPAT

Orthostatic test

1.7

14.7

298

1828

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

4.4

14.7

B94.1

ICD-10 Finland

Sequelae of viral encephalitis

25.0

14.7

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

3.7

14.6

126

XX9WW, ,

NOMESCO Finland

+∞

14.6

34509

ICD-8 Finland

Epilepsy, Absentia epileptica NUD

+∞

14.6

C71.91

ICD-10 Finland

Malignant tumor in unspecified location in the brain grade II glioma

80.2

14.6

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

3.0

14.5

217

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.9

14.5

182

972

9382/3-C71.1

ICD-O-3

Oligoastrocytoma, NOS, of frontal lobe

150.2

14.5

N06AB05

ATC

paroxetine; oral

1.6

14.5

373

2425

N02BF02

ATC

pregabalin; oral

1.6

14.4

379

2473

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.5

14.4

447

3024

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

14.3

520

3629

A10AB05

ATC

insulin aspart; parenteral

1.4

14.3

537

3772

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.7

14.3

237

1377

RS230, ,

NOMESCO Finland

3.4

14.3

152

WF099

NOMESCO Finland

Other radiotherapy

3.3

14.3

162

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.3

14.2

102

441

2151

FHL

Resection, big brain

22.3

14.2

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

6.2

14.2

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

14.1

635

4610

R06.4

ICD-10 Finland

Hyperventilation

2.2

14.1

110

493

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

3.8

14.1

111

Z2221

NOMESCO Finland

Medical doctor

1.2

14.0

1959

16561

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

14.0

1287

10371

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

14.0

613

4427

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

14.0

144

718

9539/1-C70.0

ICD-O-3

Atypical meningioma of cerebral meninges

14.4

14.0

WX402

NOMESCO Finland

General anaesthesia

1.3

14.0

1467

12013

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

14.0

663

4857

4373A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured

10.9

14.0

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

13.9

593

4262

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.1

13.9

185

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.3

13.9

102

445

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

2.2

13.9

108

483

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

3.2

13.9

170

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

15.7

13.9

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

3.6

13.9

126

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

30.0

13.9

SPAT1251

SPAT

Organisation of medication

1.7

13.8

244

1444

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

5.5

13.8

I61.6

ICD-10 Finland

Intracerebral haemorrhage, multiple localized

5.0

13.8

9401/3-C71.1

ICD-O-3

Astrocytoma, anaplastic, NOS, of frontal lobe

53.4

13.8

D33.0

ICD-10 Finland

Benign neoplasm: Brain, supratentorial

53.4

13.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

13.8

2661

23223

RS142, ,

NOMESCO Finland

4.7

13.7

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

13.7

981

7649

F81.8

ICD-10 Finland

Other developmental disorders of scholastic skills

4.6

13.7

Z72.1

ICD-10 Finland

Alcohol use

2.4

13.7

380

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.5

13.7

321

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.1

13.6

124

591

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.0

13.6

148

753

SPAT1262

SPAT

Handing over of treatment supplies

1.3

13.6

1214

9746

R93.0

ICD-10 Finland

Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified

5.1

13.6

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

13.5

1548

12799

AA11X, ,

NOMESCO Finland

+∞

13.5

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

14.7

13.5

SPAT1310

SPAT

Counselling related to known health issue

1.2

13.5

2287

19703

S70.0

ICD-10 Finland

Contusion of hip

1.7

13.5

265

1613

P16

ICPC

Acute alcohol abuse

2.2

13.5

113

522

SPAT1050

SPAT

Extensive neurological examination

1.9

13.5

153

791

N06DA02

ATC

donepezil; oral

1.5

13.4

392

2621

SPAT1210

SPAT

Application of cast or individual aid

1.6

13.3

270

1657

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.3

13.2

145

C07AB02

ATC

metoprolol; systemic

1.3

13.2

1394

11419

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

5.7

13.2

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

4.1

13.2

R4120, ,

SPAT

2.7

13.2

263

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.0

13.1

147

756

SPAT1104

SPAT

Monitoring of emergency patient

1.5

13.1

445

3066

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

5.1

13.1

F34.1

ICD-10 Finland

Dysthymia

1.7

13.1

228

1344

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.6

13.1

275

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.6

13.1

117

315

Kela drug reimbursment

Clopidogrel

2.5

13.1

334

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

13.1

165

884

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

3.7

13.0

108

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

13.0

414

2816

S09.9

ICD-10 Finland

Unspecified injury of head

2.2

13.0

110

510

GD1AA, ,

SPAT

0.7

13.0

398

5773

RL130, ,

NOMESCO Finland

3.6

13.0

113

Z43.0

ICD-10 Finland

Attention to tracheostomy

9.3

12.9

N06AA09

ATC

amitriptyline; systemic

1.4

12.9

606

4430

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

12.9

395

2666

A06

ICPC

Fainting/syncope

2.2

12.9

104

473

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

13.0

12.9

205

Kela drug reimbursment

Chronic hypertension

1.2

12.9

1888

16024

C70.0

ICD-10 Finland

Malignant neoplasm: Cerebral meninges

22.5

12.9

C71.81

ICD-10 Finland

Overall malignant tumor of the brain grade II glioma

50.0

12.8

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.9

12.8

161

861

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

12.8

631

4650

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027801) Oxygen [Partial pressure] in Arterial blood

1992

8282

2.79

319.48

7.7

7.3

14.04

12.36

kpa

24.51

1903

7865

(3003396) Base excess in Arterial blood by calculation

1988

8258

2.79

319.37

7.7

7.3

1.16

1.01

mmol/l

0.95

1554

6480

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1992

8285

2.79

319.23

7.7

7.3

5.03

5.09

kpa

1.64

1904

7871

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

482

614

8.22

307.65

1.7

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5274

32854

2.41

307.65

7.6

6.4

1.20

1.21

mmol/l

34.50

4993

29982

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2669

11400

2.88

307.65

2.4

2.3

28.96

30.00

12.63

2594

11049

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1294

357.86

307.65

2.5

2.2

54.24

36.80

umol/l

2.44

1134

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

812

1737

5.03

307.65

1.5

1.6

538.74

510.78

mg/l

0.75

781

1648

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

454

411

11.56

307.65

1.7

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4818

21515

3.58

307.65

3.5

2.1

227.58

218.14

u/l

0.19

4669

20130

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1000

2428

4.49

307.65

2.3

2.4

367.74

554.63

ug/l

1.09

952

2282

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

250

91.70

307.65

3.4

2.9

42.60

37.47

umol/l

0.41

228

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5570

36239

2.35

307.65

8.5

6.9

1.20

1.21

mmol/l

30.87

4898

30822

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

740

1526

5.18

307.65

1.4

1.5

3.88

3.73

mmol/l

2.59

700

1426

(3009466) Valproate [Moles/volume] in Serum or Plasma

1454

666

25.70

307.65

3.6

5.8

364.92

364.36

umol/l

0.03

1273

564

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

711

113.13

307.65

3.2

2.1

29.85

27.16

umol/l

0.71

540

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

702

1530

4.88

300.68

1.6

23.90

22.21

e6/l

0.08

566

1151

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

701

1530

4.87

299.72

1.7

1671.19

3416.04

e6/l

0.32

589

1218

(3044290) Cell count panel - Cerebral spinal fluid

672

1420

5.02

298.56

1.6

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

208

22.37

283.19

2.2

2.1

19.41

15.08

umol/l

2.82

208

(3013826) Glucose [Moles/volume] in Serum or Plasma

6074

43325

2.17

259.87

7.3

4.8

6.61

6.71

mmol/l

2.95

5847

40444

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

132

78.72

247.23

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

354

513

7.13

232.11

1.4

1.2

2.19

2.01

mmol/l

1.83

329

476

(3023183) Ammonium ion [Moles/volume] in Plasma

609

1503

4.27

221.84

2.9

31.32

34.46

umol/l

2.34

550

1356

(3022217) INR in Platelet poor plasma by Coagulation assay

4947

33937

1.98

219.00

16.1

15.5

1.23

1.28

inr

4.28

1396

9877

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

285

357

8.20

212.10

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

3310

20019

2.02

207.71

4.6

4.3

—

(3016502) Oxygen saturation in Arterial blood

1630

7438

2.45

207.57

8.5

7.7

96.03

95.64

1.49

1571

7142

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

276

345

8.21

205.74

1.2

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1530

6815

2.49

205.18

8.7

8.1

123.36

121.59

g/l

2.77

1495

6623

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

259

339

7.83

185.65

1.6

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4084

27264

1.89

185.53

4.8

3.6

46.17

79.13

ng/l

0.79

3154

18540

(3018418) pH of Serum or Plasma

3335

21172

1.90

174.16

4.2

4.1

7.40

0.38

623

4054

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2170

11890

2.08

173.57

4.0

3.8

0.81

0.82

mmol/l

1.71

2028

11133

(3016018) Differential panel - Cerebral spinal fluid

373

775

4.97

167.87

1.5

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1162

5066

2.48

160.63

7.0

8.5

24.39

24.78

mmol/l

3.63

1153

5031

(3020191) Ethanol [Moles/volume] in Serum or Plasma

306

555

5.67

160.35

1.9

1.4

0.77

1.40

promille

8.81

249

429

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

963

3840

2.68

160.15

7.3

9.8

24.27

24.25

mmol/l

0.04

942

3701

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2133

11916

2.03

160.03

2.0

1.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1059

4521

2.51

152.74

10.1

6.7

24.70

24.49

mmol/l

0.96

1012

4291

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

183

206

9.04

148.23

1.2

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1049

4551

2.47

145.83

8.2

9.4

0.73

0.67

5.14

1042

4518

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1049

4570

2.46

144.45

8.2

9.3

1.42

1.36

0.82

1040

4540

(3003181) Sodium [Moles/volume] in Urine

441

1203

3.80

139.01

1.5

71.42

64.78

mmol/l

2.12

365

973

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1352

6679

2.20

138.49

2.4

2.2

369.34

371.79

nmol/l

0.16

1238

6148

(3019060) Gas panel - Arterial blood

1066

4775

2.39

137.69

7.2

4.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1329

6539

2.20

137.44

6.6

7.4

1.46

1.36

mmol/l

2.18

1294

6341

(3024561) Albumin [Mass/volume] in Serum or Plasma

4338

31514

1.71

132.68

5.7

5.0

34.86

35.55

g/l

11.72

4066

29232

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1539

8184

2.06

129.34

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1535

8202

2.04

127.12

1.9

1.8

—

(3026008) Bacteria identified in Urine by Culture

3227

21865

1.73

125.43

3.6

3.1

—

(3033658) Prothrombin time (PT) actual/Normal

2867

18798

1.76

125.19

4.7

4.2

89.07

88.69

0.34

2791

18328

(3023410) Appearance of Cerebral spinal fluid

311

730

4.37

120.22

1.7

2.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4923

37625

1.66

119.10

8.2

6.2

10.05

11.97

umol/l

21.92

4656

35631

(3000991) Gas panel - Venous blood

1293

6662

2.09

117.45

7.3

8.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

657

2520

2.73

116.77

4.8

3.9

1.50

1.39

mmol/l

1.37

648

2476

(3043409) Potassium [Moles/volume] in Arterial blood

583

2134

2.85

113.20

5.2

4.1

3.87

3.90

mmol/l

0.87

578

2112

(3020891) Body temperature

708

2922

2.54

108.31

5.9

4.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

170

270

6.39

101.96

1.2

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1348

7404

1.96

101.33

4.2

4.5

5.89

5.82

kpa

1.63

1312

7183

(3015377) Calcium [Moles/volume] in Serum or Plasma

3359

24072

1.62

99.24

4.3

3.3

2.34

2.35

mmol/l

10.22

2970

21146

(3024354) Oxygen [Partial pressure] in Venous blood

1169

6159

2.03

98.79

4.0

4.1

4.66

kpa

0.02

1135

5955

(3002032) Base excess in Venous blood by calculation

1336

7377

1.95

98.67

4.2

4.5

1.97

1.80

mmol/l

1.02

1158

6177

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

145

203

7.24

97.88

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

890

4282

2.19

95.42

1.6

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

140

196

7.23

94.50

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

141

200

7.14

94.06

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

133

181

7.44

92.07

1.1

—

(3012544) pH of Venous blood

1351

7649

1.90

92.03

4.2

4.5

7.37

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

200

6.99

90.28

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1638

9964

1.78

88.07

5.6

6.4

1.03

1.06

mmol/l

4.68

1523

9275

(3036489) Thrombin time

642

2800

2.39

86.62

2.5

2.7

21.37

21.75

0.69

584

2457

(3031040) Bacteria [#/volume] in Urine by Automated count

5836

48475

1.55

84.69

5.6

4.4

2879.35

1771.19

e6/l

0.53

102

674

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

255

670

3.88

84.58

1.1

1.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2071

13624

1.67

83.23

1.8

1.7

1193.74

1161.03

nmol/l

0.93

1632

10252

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

172

338

5.16

82.42

1.6

1.2

51.58

67.59

1.43

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1473

8840

1.79

82.39

10.0

7.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5250

42918

1.51

79.55

11.6

9.1

4.09

4.12

e9/l

0.29

4608

37303

(3044640) Blood type and Crossmatch panel - Blood

3176

23395

1.54

78.45

2.7

2.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

13.02

78.38

1.2

1.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1210

6985

1.84

76.49

6.5

7.8

7.94

9.78

mmol/l

18.24

1146

6663

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

10.08

76.02

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

258

737

3.57

75.73

1.4

1.5

277.25

280.83

mosm/kgh2o

1.32

187

574

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1120

6351

1.87

74.84

2.7

2.3

5.86

7.32

ug/l

2.53

966

5496

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6501

55982

1.54

74.23

9.6

7.4

81.22

79.74

u/l

1.41

6164

52728

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

91.94

73.99

1.1

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

157

315

5.05

73.48

3.9

12.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

147

280

5.32

72.97

1.2

1.1

716.09

399.75

ng/l

0.21

(3006315) Basophils [#/volume] in Blood

4650

37475

1.48

72.63

7.0

6.0

0.04

e9/l

11.44

4030

32284

(3013115) Eosinophils [#/volume] in Blood

4773

38693

1.48

72.20

7.4

6.3

0.18

0.20

e9/l

13.47

4177

33848

(3001604) Monocytes [#/volume] in Blood

4637

37378

1.48

72.17

7.0

6.0

0.60

0.59

e9/l

0.41

4027

32212

(3019198) Lymphocytes [#/volume] in Blood

4747

38503

1.48

71.19

7.1

6.1

1.82

1.94

e9/l

2.56

4187

33965

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

9.72

69.74

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

777

3988

2.03

69.45

11.2

10.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

4388

35156

1.47

69.36

7.5

6.6

—

(3026782) Osmolality of Urine

2172

15048

1.58

68.65

3.1

3.0

543.29

548.53

mosm/kgh2o

0.50

1898

12925

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

212

583

3.70

65.86

1.2

1.1

40.11

41.08

mg/l

0.12

184

478

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1914

13000

1.59

65.40

3.2

3.0

2.43

2.45

mmol/l

7.43

1676

11313

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

206

562

3.72

64.75

1.1

264.49

264.15

mg/l

0.01

191

490

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

159

6.60

64.75

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

100

147

6.86

64.60

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

826

4455

1.94

63.85

3.9

3.7

129.62

129.29

g/l

0.16

813

4345

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

806

4316

1.95

63.64

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2474

17894

1.52

63.54

2.5

2.4

—

(4035726) Immunohistochemistry procedure

1058

6227

1.79

61.91

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

903

5066

1.87

61.79

4.7

4.4

1.64

mmol/l

0.01

674

3712

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

651

3267

2.07

61.67

4.4

4.2

50.74

48.38

1.69

645

3223

(3027273) Bicarbonate [Moles/volume] in Venous blood

686

3514

2.03

61.42

3.8

3.6

25.23

25.19

mmol/l

0.10

668

3401

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

928

5296

1.84

60.05

4.8

4.4

5.22

5.13

kpa

2.91

869

5029

(3009343) pH of Capillary blood

917

5234

1.83

59.27

4.8

4.4

7.42

7.41

0.77

105

582

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

602

2978

2.09

59.21

8.7

4.9

1.74

1.65

1.16

564

2776

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2996

22819

1.46

58.52

3.1

2.6

56.58

63.59

u/l

1.17

2785

21110

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

192

535

3.64

58.52

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

596

2954

2.09

58.30

8.9

4.9

0.92

0.89

558

2758

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

9.27

58.26

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

146

6.35

55.28

1.1

1.4

—

(3016038) Potassium [Moles/volume] in Urine

174

482

3.66

53.52

1.4

33.95

35.28

mmol/l

0.31

149

424

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

238

802

3.02

53.41

1.5

1.7

—

(3019150) Specific gravity of Urine by Refractometry

2179

15859

1.49

52.53

5.0

4.0

1.02

kg/l

0.03

301

2418

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

164

445

3.73

52.00

1.6

—

(40761535) Cells panel - Urine sediment

986

5983

1.72

51.33

3.8

3.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4192

34492

1.39

50.96

2.9

2.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3060

23878

1.42

50.57

4.2

3.3

32.41

34.67

u/l

0.73

2890

22603

(3022096) Basophils/100 leukocytes in Blood

4129

34071

1.38

48.42

7.1

6.3

0.63

0.67

5.13

3876

31774

(3021960) Folate [Moles/volume] in Serum or Plasma

2240

16627

1.46

48.14

1.7

1.5

18.42

20.12

nmol/l

6.58

1987

14271

(1761868) Lipid panel - Serum or Plasma

1897

25528

0.68

47.93

2.9

2.8

—

(3036180) Methadone [Presence] in Urine

144

378

3.85

47.91

1.7

3.0

—

(3039000) Anion gap in Blood

367

1620

2.32

47.81

12.0

6.5

10.99

11.31

mmol/l

0.93

332

1444

(3018572) Chloride [Moles/volume] in Blood

367

1621

2.32

47.74

12.0

6.5

104.61

105.04

mmol/l

0.70

332

1445

(3006504) Eosinophils/100 leukocytes in Blood

4225

35164

1.37

46.14

7.2

6.3

2.62

2.89

11.28

3967

32848

(3019069) Monocytes/100 leukocytes in Blood

4245

35369

1.37

45.99

7.5

6.6

8.95

8.61

8.98

3985

33094

(3010421) pH of Blood

415

1967

2.16

45.47

4.2

4.3

7.41

7.42

1.82

358

1788

(3030467) Casts [#/volume] in Urine by Automated count

2689

20822

1.41

45.26

3.6

3.3

0.42

0.43

e6/l

0.04

2154

15867

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1944

14216

1.46

44.64

4.5

3.8

227.75

525.76

ng/l

3.29

1523

11057

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

161

480

3.39

44.33

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

720

4163

1.79

44.11

4.3

5.1

24.10

24.00

mmol/l

0.41

706

4084

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1330

9028

1.55

43.64

2.3

1.7

1.72

1.45

19.06

1181

7914

(3002582) Erythrocytes [#/volume] in Urine

2879

22725

1.39

42.70

3.7

3.4

58.77

96.06

e6/l

1.76

2318

17475

(3002030) Lymphocytes/100 leukocytes in Blood

4321

36402

1.35

42.18

7.3

6.4

26.66

28.12

13.36

4071

34142

(3000850) Epithelial cells [#/volume] in Urine

2113

15854

1.43

41.89

2.9

2.7

5.66

5.32

e6/l

0.59

1951

14186

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

12.05

41.86

1.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

7.04

41.82

1.5

1.1

48.83

57.54

0.52

(3029937) Albumin [Presence] in Urine by Test strip

2503

19354

1.40

41.79

4.9

4.0

0.00

estimate

2.60

739

6522

(40758558) Short blood count panel - Blood

2450

18904

1.40

41.33

8.4

7.1

—

(3047181) Lactate [Moles/volume] in Blood

457

2335

2.01

40.93

11.0

5.6

1.46

1.31

mmol/l

1.36

407

2055

(36304419) Bacteria [Presence] in Urine

2599

20282

1.39

40.91

3.6

3.2

—

(3018010) Neutrophils/100 leukocytes in Blood

4252

35840

1.34

40.85

7.0

6.1

57.88

56.96

4.94

4008

33595

(3028271) Lactate [Moles/volume] in Capillary blood

281

1182

2.42

40.83

2.3

1.9

2.29

1.70

mmol/l

7.95

275

1158

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

215

4.55

40.42

1.4

1.2

22.12

31.79

0.53

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

488

2573

1.95

39.92

3.5

3.9

0.36

0.34

u/ml

0.80

324

1455

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

521

2808

1.91

39.90

2.0

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5554

48817

1.34

39.67

4.5

3.1

65.30

47.26

u/l

25.68

5254

45502

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

199

719

2.81

39.42

1.6

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2237

17111

1.40

39.35

4.4

3.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.06

39.29

1.1

—

(3012501) Base excess in Blood by calculation

357

1696

2.15

38.87

4.3

4.4

2.29

2.50

mmol/l

0.81

253

1125

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

849

5314

1.66

38.85

1.9

1.7

—

(3013290) Carbon dioxide [Partial pressure] in Blood

357

1697

2.15

38.81

4.3

4.5

5.06

4.99

kpa

1.12

349

1661

(3018095) Leukocytes [#/volume] in Urine

3244

26402

1.35

38.68

4.3

3.8

97.77

94.08

e6/l

0.06

2463

18735

(3027315) Oxygen [Partial pressure] in Blood

358

1706

2.14

38.67

4.3

4.4

8.63

8.66

kpa

0.15

350

1669

(3028707) Methadone [Presence] in Urine by Screen method

304

1357

2.28

38.58

3.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

8049

75374

1.52

38.44

27.1

16.3

138.42

139.67

mmol/l

197.25

7927

73397

(3037467) Urinalysis macro (dipstick) panel - Urine

5741

50850

1.34

38.10

5.2

4.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

420

2162

1.99

36.81

1.3

—

(1616796) Gas panel - Central venous blood

353

1711

2.10

36.48

3.7

3.8

—

(3015736) pH of Urine

3517

29205

1.33

35.79

4.1

3.3

6.12

5.88

2.69

155

2206

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

435

2300

1.93

35.26

3.1

3.3

3.42

3.51

g/l

0.66

416

2187

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

523

2940

1.82

35.03

2.5

1.9

2.87

2.33

ug/l

0.34

436

2585

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2418

19059

1.36

34.61

2.3

2.95

2.94

mg/l

0.08

2034

16329

(3019225) pH of Specimen

1041

7035

1.54

34.28

4.6

4.3

—

(40767503) Oxygen content in Capillary blood by calculation

330

1603

2.10

33.92

2.7

2.5

16.96

16.40

1.46

163

840

(3035350) Ketones [Presence] in Urine by Test strip

4211

36074

1.31

33.46

4.5

3.6

0.00

estimate

3.26

824

7199

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3522

29482

1.31

33.03

2.1

2.0

94.08

95.06

pmol/l

0.60

1960

15607

(3023103) Potassium [Moles/volume] in Serum or Plasma

8028

75600

1.46

32.56

26.5

16.4

3.97

mmol/l

0.42

7889

73475

(3015235) Bicarbonate [Moles/volume] in Capillary blood

377

1958

1.96

32.20

3.5

3.4

24.40

24.67

mmol/l

0.69

369

1915

(3028626) Oxygen [Partial pressure] in Capillary blood

429

2347

1.87

31.32

5.4

4.9

8.81

8.65

kpa

0.94

418

2286

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

121

377

3.24

31.15

1.1

1.06

1.08

u/l

0.13

176

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1689

12757

1.40

30.93

3.1

2.9

1.21

1.13

e6/l

0.36

990

7351

(3009261) Glucose [Presence] in Urine by Test strip

4218

36406

1.29

30.61

4.5

3.6

0.00

estimate

2.20

755

6619

(3007853) Bacteria identified in Skin by Aerobe culture

1244

8915

1.46

30.51

1.9

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

580

3502

1.70

30.24

5.5

4.9

24.80

24.66

mmol/l

0.51

542

3257

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1195

8515

1.46

30.17

4.5

4.3

253.67

242.86

u/l

0.72

1125

8041

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

132

442

3.01

30.10

1.0

281.54

312.23

ng/l

0.70

302

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

131

446

2.96

29.03

1.0

37.59

42.94

ng/l

0.92

302

(3021601) Nitrite [Presence] in Urine by Test strip

4163

36023

1.28

29.02

5.8

4.9

0.00

estimate

0.80

774

6808

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

100

5.52

28.86

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

130

443

2.96

28.76

1.0

753.03

736.54

ng/l

0.14

294

(3022806) Fractional oxyhemoglobin in Capillary blood

216

953

2.30

28.25

2.2

1.9

89.25

89.71

0.58

210

942

(3022313) Gas panel - Capillary blood

626

3924

1.64

28.24

5.1

4.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7875

74351

1.39

27.30

22.8

14.2

24.14

24.27

mg/l

0.14

6868

58752

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

103

5.27

26.92

1.1

1.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2015

15976

1.33

26.52

2.1

1.9

1.22

1.24

mg/l

0.12

1557

12139

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

390

2198

1.81

25.87

3.6

3.2

186.50

188.29

0.15

371

2095

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.13

25.74

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

508

3093

1.68

25.63

2.1

1.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

381

6481

0.57

25.27

1.7

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

8.88

25.02

1.8

1.2

29.63

39.19

0.44

(3042936) Bacteria identified in Isolate by Culture

1386

10466

1.38

24.86

2.2

2.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

9.11

24.69

1.2

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

212

992

2.16

24.09

6.1

6.8

10.73

11.59

mg/l

1.89

186

911

(3014271) Vancomycin [Susceptibility]

107

362

2.98

24.05

3.0

2.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1930

15415

1.32

23.74

1.7

32591676.24

30378592.90

pmol/l

0.06

1617

12825

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3247

27744

1.26

23.44

4.8

3.8

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

19.51

23.38

1.1

1.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2490

20610

1.28

23.33

3.1

3.2

1511.43

1530.64

ng/l

0.07

2161

17674

(3027945) Reticulocytes/100 erythrocytes in Blood

1163

8636

1.40

22.94

2.9

2.7

1.82

1.74

1.72

1023

7657

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.69

22.90

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1537

11943

1.34

22.77

3.3

3.0

3.34

2.31

e6/l

2.92

849

6580

(3052851) Hemolysis interference index of Serum or Plasma

385

2249

1.74

22.61

3.5

3.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

162

700

2.34

22.32

2.6

3.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

330

2.99

22.24

2.6

2.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

409

2449

1.70

21.97

2.9

3.3

95.02

91.33

2.31

393

2357

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6068

55830

1.25

21.90

4.3

3.9

14.37

14.79

pmol/l

28.68

5555

50729

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

312

3.03

21.88

1.9

2.3

145.71

151.74

umol/l

0.06

170

(3024869) Neuronal Ab [Presence] in Serum

119

4.47

21.87

1.1

—

(21494755) Public health laboratory ask at order entry panel

448

7057

0.62

21.78

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

300

1655

1.84

21.38

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

300

1655

1.84

21.38

1.4

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

808

5694

1.46

21.26

2.5

2.7

10.14

10.44

g/l

0.94

738

5218

(3023520) Reticulocytes [#/volume] in Blood

893

6412

1.43

21.25

2.7

2.6

70.44

69.14

e9/l

0.47

666

4799

(3021901) Oxygen saturation in Capillary blood

265

1408

1.91

21.24

2.9

3.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

6.12

21.05

1.2

1.1

11.83

20.06

—

(3035637) Corticotropin [Mass/volume] in Plasma

209

1027

2.06

20.95

1.5

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

104

377

2.78

20.67

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

235

4339

0.53

20.66

1.5

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

281

3.08

20.60

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

404

2471

1.66

20.04

2.8

2.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6704

70947

0.80

19.27

4.4

4.2

1.45

1.44

mmol/l

2.46

6183

65540

(3021589) Normoblasts [#/volume] in Blood

3751

33118

1.22

18.71

11.5

9.7

0.00

e9/l

0.45

3051

26922

(3020630) Protein [Mass/volume] in Serum or Plasma

830

6023

1.41

18.54

2.3

2.5

65.86

66.32

g/l

0.83

748

5475

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

940

6973

1.39

18.46

2.5

2.4

0.21

g/l

0.11

868

6480

(3016879) Cocaine [Presence] in Urine

458

2955

1.58

18.29

2.6

2.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

646

4493

1.47

18.14

1.3

37.55

55.23

au/ml

1.98

242

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

694

4913

1.45

17.76

2.3

2.4

29.30

22.66

au/ml

0.63

372

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

203

1050

1.95

17.69

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6784

71481

0.81

17.15

4.4

4.3

4.56

4.61

mmol/l

3.67

6290

66390

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6924

72785

0.81

17.02

4.9

4.7

2.66

2.74

mmol/l

9.59

6395

67214

(3000764) Benzodiazepines [Presence] in Urine

477

3162

1.54

16.90

2.5

2.2

—

(3028300) Cannabinoids [Presence] in Urine

479

3185

1.53

16.73

2.6

2.2

—

(3027008) Opiates [Presence] in Urine

478

3180

1.53

16.66

2.5

2.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

102

411

2.50

16.51

2.3

2.5

44.99

56.73

umol/l

0.20

(3024928) Oxygen saturation in Venous blood

275

1599

1.74

16.50

3.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.36

16.09

1.7

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

350

2196

1.62

15.74

1.7

—

(3011288) Drugs identified in Urine by Screen method

338

2115

1.62

15.38

3.5

3.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

169

865

1.97

15.24

10.0

7.3

7.21

7.34

mmol/l

0.19

142

719

(3027944) Amphetamines [Presence] in Urine

463

3120

1.51

15.20

2.3

2.1

—

(3017569) Oxygen content in Arterial blood

336

2.57

14.89

1.7

2.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

344

2.54

14.70

1.8

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

790

5945

1.36

14.08

4.1

4.0

1.22

1.23

mmol/l

5.66

737

5180

(4034850) Laboratory test

357

2314

1.56

14.03

12.1

9.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

215

1227

1.77

13.83

1.6

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

215

1227

1.77

13.83

1.6

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

962

7477

1.32

13.77

4.2

3.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3342

29791

1.19

13.66

2.3

73.72

76.55

nmol/l

6.89

2976

26855

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

162

869

1.88

12.78

1.5

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

162

869

1.88

12.78

1.5

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.86

12.75

1.1

2.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

194

1105

1.77

12.60

1.4

1.3

3.70

4.25

u/ml

0.35

491

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

236

1421

1.68

12.56

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

482

3401

1.44

12.56

1.9

1.7

1.50

1.53

g/l

0.19

391

2926

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

367

2457

1.51

12.48

2.5

2.7

—

(3011412) CD3 cells [#/volume] in Blood

150

794

1.90

12.34

2.4

2.6

1.12

1.20

e9/l

0.46

133

695

(3013512) EKG study

2366

20595

1.20

12.33

4.5

3.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

655

4891

1.36

12.25

2.0

2.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

339

2.40

12.20

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1434

11904

1.24

11.98

2.6

12.72

13.04

umol/l

0.83

1312

11096

(3008757) Leukocyte morphology finding [Identifier] in Blood

152

819

1.87

11.86

3.3

4.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

5774

54200

1.17

11.83

4.2

4.0

12.61

11.95

mm/h

2.46

5387

50099

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

277

1770

1.58

11.64

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1330

11005

1.24

11.40

2.6

2.30

2.33

g/l

1.48

1220

10178

(3011985) Renin [Units/volume] in Plasma

169

955

1.78

11.33

1.6

1.5

65.78

68.22

mu/l

0.06

156

844

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

280

1809

1.56

11.23

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6549

68518

0.85

11.19

4.0

3.8

1.30

1.29

mmol/l

0.15

6028

62808

(3051651) Icteric interference index of Serum or Plasma

460

2.12

10.90

2.8

4.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

210

1276

1.66

10.86

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

243

2.56

10.78

1.4

1.5

13.30

15.46

pmol/l

1.65

202

(3006184) Hemoglobin [Mass/volume] in Capillary blood

268

1732

1.56

10.75

2.3

2.2

132.47

129.79

g/l

1.08

221

1254

(3017181) Myelocytes/100 leukocytes in Blood

796

6234

1.30

10.72

4.2

1.21

0.94

2.04

362

2123

(3028433) Virus identified in Specimen by Culture

274

2.45

10.67

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

202

1238

1.65

10.13

3.0

3.6

1.51

1.49

0.03

183

1089

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

188

1131

1.68

10.13

1.4

1.3

5.03

3.75

u/ml

0.40

370

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

118

3.23

10.09

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

110

565

1.96

9.99

2.4

2.9

0.22

e9/l

0.09

477

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

113

586

1.94

9.98

2.4

2.8

493.23

506.51

e6/l

0.11

482

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1237

10308

1.23

9.85

2.7

2.6

22.58

22.55

0.02

1023

8814

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

329

2.26

9.80

1.2

1.1

1673.29

1532.49

miu/ml

0.45

329

(40761511) CBC panel - Blood by Automated count

7942

76995

1.22

9.72

21.1

13.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

261

1718

1.53

9.69

1.5

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

297

2011

1.49

9.64

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.92

9.56

1.0

—

(40757373) Influenza virus identified in Isolate

149

2.89

9.50

1.6

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

135

754

1.80

9.49

2.8

3.0

20.37

20.08

nmol/l

0.12

123

724

(3001019) Free T4 and TSH panel - Serum or Plasma

236

3553

0.66

9.31

1.7

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

566

4314

1.33

9.28

2.8

3.3

4.28

4.50

pmol/l

4.89

508

3813

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.45

9.16

2.0

4.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

854

6890

1.26

9.07

2.6

2.5

41.57

44.69

u/l

0.13

727

5888

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

154

909

1.71

8.96

1.2

1.4

294.61

345.03

pmol/l

0.61

135

774

(3044889) 12 lead EKG panel

5342

50359

1.14

8.82

4.1

3.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1246

14662

0.83

8.73

2.7

3.0

0.74

0.77

ug/l

0.23

872

9724

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

113

614

1.85

8.72

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

113

614

1.85

8.72

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

113

614

1.85

8.72

1.5

1.7

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.65

8.69

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

243

1618

1.51

8.60

1.3

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

717

5704

1.28

8.56

3.9

4.1

0.86

0.68

1.39

313

1859

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

12.74

8.35

1.2

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.30

8.31

1.5

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

430

1.98

8.14

2.9

2.6

43.67

39.64

1.23

241

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

729

5851

1.27

8.09

3.3

2.6

70.56

66.37

ml/min/173m2

1.65

306

2328

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

8.90

8.02

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6983

67250

1.15

7.88

5.3

4.6

2.01

2.16

mu/l

0.35

6478

61621

(3021387) Prolactin [Units/volume] in Serum or Plasma

358

2609

1.39

7.87

1.8

1.6

361.14

295.42

mu/l

2.63

325

2364

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

159

983

1.63

7.81

1.4

22.34

25.29

u/l

0.64

134

821

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

138

2.76

7.77

1.3

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

504

3880

1.32

7.74

3.0

2.8

0.32

0.28

e6/l

0.26

493

3786

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

316

2266

1.41

7.65

2.2

1.7

1.18

g/l

0.05

301

2147

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

187

1209

1.56

7.62

3.0

3.9

391.91

1642.81

u/ml

1.18

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

109

612

1.79

7.62

2.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

115

657

1.76

7.58

2.3

2.4

74.41

71.11

1.74

110

627

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

307

2196

1.41

7.55

2.2

1.7

0.23

g/l

0.71

293

2079

(3019977) pH of Arterial blood

401

1.98

7.53

3.2

2.6

7.42

7.43

0.47

143

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

342

2.05

7.42

4.4

1.9

160.91

143.94

0.94

325

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1015

8524

1.21

7.42

3.2

3.1

6.62

8.26

umol/l

3.78

849

7399

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

229

1556

1.48

7.41

5.4

6.2

335.86

2194.34

iu/ml

1.00

235

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

361

2665

1.37

7.36

2.4

2.3

5861.76

5585.12

u/l

0.05

1038

(3042517) Benzodiazepines panel - Urine

3.34

7.36

3.8

2.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

731

5937

1.25

7.34

4.3

0.15

0.11

0.64

301

1837

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

154

2.60

7.33

1.1

1.2

75.29

70.81

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

199

1317

1.52

7.31

1.9

1.8

—

(40768804) Tissue Pathology biopsy report

3153

28955

1.13

7.31

2.2

2.1

—

(3052592) Norovirus Ag [Presence] in Stool

143

2.66

7.28

1.8

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

520

1.83

7.24

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

128

765

1.68

7.20

3.0

3.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

154

965

1.61

7.20

1.2

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

210

2.34

7.17

4.0

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

210

2.34

7.17

4.0

2.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

220

3181

0.68

7.14

1.4

1.5

—

(3037121) Protein [Mass/volume] in Urine

358

2654

1.36

7.12

3.5

0.25

0.34

g/l

1.91

194

1230

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

128

769

1.67

7.07

2.5

2.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

209

1410

1.49

7.03

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

152

2.57

6.99

1.1

1.2

63.57

78.00

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

125

751

1.67

6.92

2.7

3.6

59.32

56.02

0.97

106

631

(3035285) Chloride [Moles/volume] in Venous blood

145

905

1.61

6.91

3.5

2.3

104.32

105.57

mmol/l

1.99

145

894

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

164

1054

1.57

6.90

1.2

1.1

119.00

114.91

0.81

144

946

(3000093) Morphology [Interpretation] in Blood Narrative

120

714

1.69

6.89

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

145

907

1.61

6.85

3.5

2.3

4.05

4.08

mmol/l

0.45

145

896

(3049233) Organic acids panel - Urine

6.08

6.75

1.4

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.46

6.59

2.4

5.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

141

885

1.60

6.58

3.6

2.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

414

3182

1.31

6.48

1.5

1.6

32.41

15.39

u/ml

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

139

875

1.60

6.42

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

484

1.80

6.35

1.4

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

4.05

6.34

1.1

1.54

5.20

u/l

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.16

6.27

2.4

2.1

—

(3017509) Phencyclidine [Presence] in Urine

3.20

6.13

1.5

1.6

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

12.51

6.07

1.1

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

406

1.85

5.99

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

158

1044

1.52

5.94

2.5

2.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

473

1.78

5.92

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

270

2.04

5.84

4.4

1.9

175.78

170.59

0.15

254

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1674

18682

0.87

5.83

1.6

1.36

1.37

mmol/l

0.25

1441

15772

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

626

7584

0.81

5.82

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

231

2.13

5.79

1.1

79.17

87.81

0.50

116

(3025159) Blasts/100 leukocytes in Blood

682

5647

1.22

5.76

4.3

0.25

0.37

0.25

252

1562

(3028026) IgM [Mass/volume] in Serum or Plasma

549

4443

1.25

5.74

1.8

1.9

1.18

1.32

g/l

1.58

497

4063

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

159

1069

1.50

5.53

1.8

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

311

1.93

5.50

1.2

1.3

160.30

165.85

mmol/24h

0.16

311

(3011648) Oxygen content in Venous blood

102

624

1.64

5.37

5.2

4.0

11.35

11.20

0.12

102

624

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

329

2522

1.32

5.32

1.6

473.85

301.01

titre

0.28

104

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

147

981

1.51

5.32

1.3

0.19

0.27

nmol/l

0.59

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

226

2.08

5.31

1.1

1.2

69.73

86.27

1.02

116

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

155

2.33

5.31

2.7

2.3

1.46

1.66

mmol/l

0.12

111

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8012

78437

1.16

5.29

14.4

10.1

26.85

26.64

u/l

0.26

7816

75566

(3024666) Lithium [Moles/volume] in Serum or Plasma

409

1.79

5.27

12.5

12.0

0.61

0.62

mmol/l

0.13

377

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

119

1819

0.65

5.22

1.4

1.5

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

+∞

5.21

2.6

0.0

288.00

—

umol/l

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

310

2365

1.32

5.20

1.5

10.43

8.99

u/l

0.98

250

1859

(3039443) Prostate specific Ag panel - Serum or Plasma

1399

0.60

5.16

1.6

—

(3037756) Immunofixation for Serum or Plasma

210

1510

1.40

5.15

1.4

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

143

956

1.50

5.14

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.79

5.12

2.3

1.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

162

1113

1.46

5.10

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

661

5530

1.21

5.06

4.0

4.2

81.66

90.45

ng/l

1.93

569

4804

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

122

792

1.55

5.04

1.2

1.1

92.14

95.66

0.81

111

741

(40768800) Prostate Pathology biopsy report

1546

0.63

4.99

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

145

2108

0.68

4.97

1.6

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

359

1.82

4.95

2.6

27.93

28.01

0.02

343

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

109

1674

0.65

4.92

1.3

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

375

1.79

4.89

2.6

2.8

10.26

12.24

0.53

354

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

109

1667

0.65

4.83

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

109

1667

0.65

4.83

1.3

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

2.82

4.80

1.1

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

161

1119

1.45

4.79

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

222

2.03

4.79

2.3

3.3

—

(3000494) Fungus identified in Specimen by Culture

978

8511

1.17

4.76

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

110

1672

0.65

4.74

1.3

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3431

32230

1.10

4.73

3.1

2.9

142.49

127.18

ug/l

1.64

3147

29857

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

740

6299

1.19

4.71

3.0

176.96

212.83

ng/l

2.11

673

5709

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

117

772

1.52

4.53

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

290

1.87

4.52

2.8

2.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1361

0.63

4.48

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.27

4.46

3.9

3.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

265

2028

1.32

4.41

1.3

1.5

15.43

14.12

iu/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

271

2081

1.31

4.40

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

273

2100

1.31

4.38

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

269

2068

1.31

4.33

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

195

2619

0.74

4.23

1.6

1.7

6.32

3.93

mg/l

0.98

153

1892

(42529406) Shigella sp [Presence] in Stool by Culture

273

2111

1.30

4.22

1.2

—

(3005033) Fetal Nuchal fold Thickness US

1353

0.64

4.22

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1396

0.65

4.15

1.4

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

286

2231

1.29

4.15

2.4

3.3

31.01

53.18

mg/l

2.64

249

1815

(3034860) Kappa light chains.free [Mass/volume] in Serum

286

2233

1.29

4.12

2.4

3.3

47.23

83.76

mg/l

0.78

248

1816

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

345

1.74

4.06

1.1

30.17

17.36

u/ml

—

(3003694) ABO and Rh group [Type] in Blood

2249

20824

1.11

4.04

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

175

2.06

4.03

1.1

1.2

359.04

286.32

pmol/l

0.47

122

(43055514) Macroprolactin [Presence] in Serum or Plasma

175

2.06

4.03

1.4

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

10.00

4.00

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

190

2.00

3.96

1.4

118.56

132.99

nmol/l

0.22

141

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

999

11257

0.87

3.94

1.3

18.45

11.64

u/ml

0.51

389

4349

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

336

1.73

3.85

3.4

3.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

681

7870

0.85

3.80

1.6

1.7

—

(3000492) Spirometry study

616

7174

0.85

3.79

1.5

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

540

1.56

3.73

1.4

1.5

12.90

12.81

u/l

0.04

519

(3003434) Protein [Mass/volume] in Pleural fluid

141

1007

1.41

3.71

1.4

1.5

33.80

32.22

g/l

0.80

135

905

(3023511) Choriogonadotropin [Units/volume] in Urine

177

1313

1.35

3.70

1.5

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

276

2179

1.27

3.69

2.4

3.3

18.78

2.93

ratio

0.42

169

(3020911) Cortisol [Moles/time] in 24 hour Urine

245

1.84

3.68

1.4

134.33

194.62

nmol/24h

0.42

245

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

131

927

1.42

3.64

1.4

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

142

2.12

3.63

1.2

1.1

0.80

0.69

umol/24h

0.48

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

133

947

1.41

3.58

1.4

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

322

2601

1.25

3.55

2.1

2.3

3.03

2.96

g/l

0.45

274

2335

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

122

860

1.42

3.48

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

338

2752

1.24

3.48

1.2

0.53

0.91

u/ml

0.74

257

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

342

2789

1.23

3.47

2.1

2.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

112

2.23

3.46

1.0

1.3

42.24

98.03

ng/l

0.99

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

463

1.58

3.46

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

355

1.67

3.45

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

355

1.67

3.45

1.4

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

342

2791

1.23

3.45

2.1

2.3

7.26

7.42

g/l

0.94

294

2520

(3017315) Amylase [Enzymatic activity/volume] in Urine

378

1.64

3.45

1.1

1.3

340.35

340.20

u/l

0.00

346

(3006922) Hepatitis E virus Ab [Presence] in Serum

503

1.55

3.45

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

140

1016

1.38

3.39

1.6

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

209

1.87

3.37

1.1

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

129

925

1.40

3.36

1.4

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

340

2787

1.23

3.30

2.1

2.3

3.60

3.69

g/l

0.55

293

2520

(3033086) Enterovirus NOS Ab [Titer] in Serum

4.35

3.30

1.1

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

292

2356

1.25

3.29

2.0

2.3

0.71

0.92

g/l

0.45

237

2025

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6466

66220

0.92

3.28

5.8

5.6

39.32

39.75

mmol/mol

2.89

5985

61338

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

102

2.26

3.28

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

160

1194

1.35

3.27

1.1

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.29

3.25

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

129

931

1.39

3.25

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

220

1.82

3.21

1.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

6.36

3.18

1.0

1.1

3.04

1.14

mg/l

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

128

927

1.39

3.17

1.4

1.5

—

(3008898) HLA-B27 [Presence]

193

2481

0.77

3.15

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

296

1.69

3.14

1.8

2.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

128

930

1.38

3.11

1.4

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1085

11985

0.89

3.11

1.2

1.3

28.86

31.42

iu/ml

0.23

297

3717

(3023199) Leukocytes [#/volume] in Pleural fluid

124

897

1.39

3.10

1.4

1.5

2423.75

2353.44

e6/l

0.05

102

647

(4094501) Cardiovascular stress test using bicycle ergometer

143

1908

0.75

3.07

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

238

1.77

3.07

2.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

122

882

1.39

3.06

1.8

2.1

47.89

23.40

mg/l

2.01

220

(3000060) B lymphocytes [#/volume] in Blood

291

1.69

3.05

2.6

2.8

959.58

319.18

e6/l

0.37

170

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

316

2595

1.22

3.05

2.1

2.3

10.11

10.21

g/l

0.15

268

2306

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

259

2082

1.25

3.04

1.9

2.2

0.03

0.04

g/l

0.19

224

1906

(3015076) Soybean IgE Ab [Units/volume] in Serum

453

0.48

3.03

1.1

1.43

2.19

u/ml

—

161

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.50

3.03

1.5

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.33

3.01

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

278

1.69

2.97

3.1

2.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

241

1931

1.25

2.93

2.0

2.2

0.01

0.00

g/l

0.45

206

1763

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

373

1.58

2.89

2.3

1.8

1.28

3.13

u/field

1.86

261

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.09

2.87

1.1

4.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

542

1.48

2.87

1.2

1.3

11.70

12.75

u/l

0.35

496

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

268

2179

1.24

2.86

1.9

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

106

760

1.40

2.82

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1072

0.68

2.81

1.1

2.77

3.49

u/ml

0.38

485

(3007164) IgA [Mass/volume] in Serum or Plasma

1587

14688

1.10

2.81

1.5

2.33

2.38

g/l

0.46

950

8832

(3017732) Neutrophils [#/volume] in Blood

582

5081

1.15

2.81

3.5

2.8

4.41

4.98

e9/l

1.10

452

4113

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1907

20378

0.92

2.77

4.0

4.2

21.44

22.05

0.95

921

9870

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

254

1.70

2.76

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

153

1167

1.32

2.75

1.2

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

264

2154

1.23

2.74

1.9

2.1

37.08

37.65

g/l

0.71

216

1881

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1773

16522

1.09

2.69

1.3

1.44

1.95

u/ml

1.28

471

4286

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

257

2099

1.23

2.66

1.4

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

303

1.62

2.66

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

235

1902

1.24

2.65

2.0

2.3

0.00

g/l

-0.00

206

1758

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

343

1.58

2.63

1.3

1.6

2.16

5.58

nmol/l

1.45

277

(3028308) Erythrocytes [#/volume] in Pleural fluid

110

806

1.37

2.60

1.4

1.5

67415.05

58166.55

e6/l

0.14

474

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.25

2.60

3.4

2.5

0.61

0.55

u/field

0.09

(3020874) Milk IgE Ab [Units/volume] in Serum

517

0.56

2.58

1.1

1.2

0.80

3.29

u/ml

1.75

222

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

247

2018

1.23

2.56

1.4

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

615

1.42

2.55

1.2

1.3

—

143.75

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

615

1.42

2.55

1.2

1.3

207.50

200.99

titre

0.03

121

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

7.14

2.55

1.2

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

7.14

2.55

1.2

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

355

3008

1.19

2.52

1.8

1.9

39.39

39.09

u/l

0.09

319

2658

(3022621) pH of Urine by Test strip

546

4786

1.15

2.52

3.6

2.9

—

(3026250) Tacrolimus [Mass/volume] in Blood

363

1.55

2.51

33.6

36.5

7.02

7.22

ug/l

0.30

336

(3007566) Smooth muscle Ab [Titer] in Serum

249

2041

1.23

2.51

1.3

120.00

148.66

titre

0.19

172

(3038177) Helicobacter pylori Ab [Presence] in Serum

1197

0.72

2.50

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

136

1.91

2.49

1.2

0.89

129.34

mg/l

1.44

105

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

117

1543

0.75

2.40

1.5

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

189

1.75

2.40

1.2

1.1

—

(4200892) Spirometry reversibility

576

5088

1.14

2.39

1.5

1.4

—

(3045424) Erythrocytes [Presence] in Urine

153

1193

1.29

2.39

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

517

0.58

2.39

1.2

1.65

8.32

u/ml

—

190

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

160

1.81

2.38

2.7

—

(3034770) Mitochondria Ab [Titer] in Serum

246

2027

1.22

2.38

1.3

656.00

1029.49

titre

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2424

25522

0.93

2.37

4.3

4.9

3.14

3.25

ug/l

0.10

2152

22908

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

119

898

1.33

2.36

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

143

1108

1.29

2.35

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.82

2.33

1.5

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

964

8790

1.11

2.33

1.7

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

209

1697

1.24

2.33

2.6

3.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

156

1226

1.28

2.30

1.7

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

469

1.45

2.30

1.1

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

155

1.81

2.28

1.7

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.37

2.28

1.2

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

4.62

2.27

1.0

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.48

2.26

1.5

1.3

521.88

542.87

nmol/l

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

471

1.45

2.26

1.1

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1206

0.74

2.22

1.4

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

132

1023

1.29

2.19

1.4

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

192

1557

1.24

2.19

1.4

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

101

755

1.34

2.16

1.2

—

35.22

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1483

13849

1.08

2.14

1.8

1.9

—

(3012441) Differential panel - Pleural fluid

105

791

1.33

2.14

1.4

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

104

784

1.33

2.11

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

109

829

1.32

2.09

2.6

2.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

365

1.48

2.06

1.9

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

365

1.48

2.06

1.9

2.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

151

1202

1.26

2.05

1.7

1.8

4.65

4.90

mmol/24h

0.49

137

1050

(3012920) Ethanol [Mass/volume] in Serum or Plasma

4.00

2.03

1.3

1.5

—

(3016135) IgD [Mass/volume] in Serum

4.00

2.03

1.0

1.1

24.57

70.85

mg/l

—

(3034426) Prothrombin time (PT)

262

1.57

2.02

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

294

1.53

2.01

1.0

1.3

—

(3045788) Cell count panel - Pleural fluid

696

1.34

2.00

1.4

1.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.05

2.00

4.0

3.6

9.49

3.87

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

426

1.43

1.98

1.0

1.1

0.12

10.64

nmol/l

—

(3032641) Amino acids panel - Urine

3.33

1.96

1.1

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

913

0.72

1.93

3.8

2.6

13.45

13.13

1.40

901

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

175

1429

1.23

1.91

1.8

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

282

1.53

1.91

2.0

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

282

1.53

1.91

2.0

2.3

—

(40768806) Pleura Pathology biopsy report

103

789

1.31

1.91

1.4

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

284

1.52

1.86

2.1

2.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

174

1.67

1.85

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.53

1.83

1.7

2.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

318

1.48

1.82

1.1

94.22

93.58

0.04

246

(3005082) Progesterone [Moles/volume] in Serum or Plasma

353

0.57

1.81

1.3

1.4

23.31

32.65

nmol/l

0.90

311

(3030313) Adrenal Ab [Titer] in Serum

2.12

1.81

1.8

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

238

1.56

1.80

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

527

4726

1.12

1.79

1.2

88.09

141.90

iu/ml

3.49

194

1732

(3037522) Nuclear Ab [Titer] in Serum

1054

9784

1.09

1.78

1.4

1.3

478.91

526.21

titre

0.46

220

1972

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.17

1.77

2.2

2.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

127

1011

1.26

1.77

1.5

0.34

0.37

nmol/l

0.21

102

802

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

659

1.32

1.77

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

796

7302

1.10

1.76

4.0

4.1

12.64

28.76

ug/l

1.81

649

5943

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.09

1.75

10.4

9.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

177

1.64

1.75

1.3

1.5

11.67

13.66

g/l

0.48

140

(3013293) Extractable nuclear Ab [Presence] in Serum

1.90

1.74

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

209

1.58

1.72

1.2

1.3

18.22

287.84

ug/l

1.31

105

(3012494) Peanut IgE Ab [Units/volume] in Serum

283

0.53

1.72

1.0

1.2

11.15

16.01

u/ml

—

183

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.85

1.71

1.8

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

258

1.51

1.69

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

390

1.41

1.69

1.4

5.90

7.64

ug/l

1.25

344

(3022145) Colonoscopy Study observation

734

7991

0.91

1.66

1.3

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

579

1.33

1.66

2.3

2.1

2.32

1.61

u/field

0.46

224

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

205

1729

1.19

1.65

1.9

1.8

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.93

1.64

1.1

1.0

0.01

0.62

u/ml

—

(3042631) Mycobacterium sp identified in Specimen

123

988

1.25

1.61

2.4

2.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

149

1223

1.22

1.60

1.2

1.1

7895.64

7771.72

iu/ml

0.00

308

(3004451) EKG impression Narrative

361

1.41

1.60

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.50

1.59

1.0

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

267

2311

1.16

1.58

5.9

6.0

1.50

1.46

mg/l

0.36

245

2138

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

159

1.64

1.58

1.2

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

263

1.48

1.57

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

249

2148

1.16

1.55

1.4

258.76

276.67

ug/g

0.70

144

1253

(3006442) Creatine [Moles/volume] in Serum or Plasma

500

1.34

1.54

1.8

1.5

73.75

83.47

umol/l

2.76

500

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

3.33

1.52

1.0

183.20

157.87

g/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

112

1388

0.80

1.52

1.1

3.28

2.33

u/ml

0.25

777

(37021550) Renin [Units/volume] in Plasma --upright

169

1.60

1.51

1.3

150.90

112.25

mu/l

0.22

131

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

345

0.61

1.50

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6899

69898

0.95

1.49

4.7

4.4

5.89

5.93

mmol/l

1.70

6302

63718

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

538

1.32

1.49

1.9

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

162

1.61

1.48

1.4

1.9

—

(3019174) dRVVT (LA screen)

2.00

1.48

1.1

1.2

—

(3044927) Protein electrophoresis panel - Urine

714

1.28

1.48

1.5

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

114

1403

0.81

1.46

1.9

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

402

1.37

1.46

1.7

3.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

8221

82832

0.93

1.44

33.3

20.8

132.69

135.73

g/l

65.40

8129

81613

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.03

1.43

1.3

1.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

152

0.46

1.42

1.1

10.77

57.68

u/ml

—

145

(3029075) Extractable nuclear Ab panel - Serum

226

0.53

1.41

1.0

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

8220

82812

0.93

1.41

33.0

20.7

4.39

4.51

e12/l

92.23

8050

80332

(3020393) Adenovirus Ag [Presence] in Stool

149

1.61

1.40

1.8

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

271

1.44

1.38

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

432

1.34

1.38

1.2

1.08

1.05

ratio

1.15

149

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1106

0.79

1.38

1.1

2.09

3.99

u/ml

1.73

558

(3020491) Glucose [Moles/volume] in Blood

554

1.30

1.37

1.9

2.1

7.86

6.57

mmol/l

1.86

393

(3024731) MCV [Entitic volume]

8220

82801

0.93

1.37

32.9

20.6

91.08

90.73

9.17

8126

81577

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

139

1664

0.83

1.36

1.2

1.1

1.44

2.58

u/ml

1.31

921

(3022493) Free Hemoglobin [Mass/volume] in Plasma

339

1.39

1.36

7.4

5.2

75.66

754.51

mg/l

0.49

243

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

538

1.30

1.35

1.7

1.6

—

(3035941) MCH [Entitic mass]

8220

82796

0.93

1.35

32.9

20.6

30.49

30.25

27.06

8125

81574

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.87

1.34

4.1

3.3

1.51

1.41

mg/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1001

0.79

1.33

1.3

7.04

7.24

mmol/l

0.21

888

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

232

1.47

1.33

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

465

0.69

1.33

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

488

1.31

1.32

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

426

3854

1.11

1.31

2.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1320

13907

0.94

1.31

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

559

1.29

1.30

1.1

1.0

282.35

284.40

mg/l

0.07

503

(3020682) Albumin/Creatinine [Ratio] in Urine

2129

22129

0.95

1.30

3.8

3.9

12.06

9.66

mg/mmol

1.07

1386

14285

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.09

1.30

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

761

0.76

1.29

1.1

1.2

—

(3010813) Leukocytes [#/volume] in Blood

8224

82817

0.93

1.29

33.0

20.7

6.83

6.78

e9/l

1.10

8058

80308

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.78

1.28

1.0

2.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

276

1.41

1.27

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

221

1924

1.15

1.27

1.9

11.60

11.43

mg/l

0.10

200

1795

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

348

3120

1.12

1.27

1.1

1.08

10.07

u/ml

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

109

892

1.22

1.27

2.0

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.94

1.27

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

164

1395

1.18

1.27

3.5

3.1

0.72

0.83

nmol/l

4.38

125

1050

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.05

1.26

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

138

1.59

1.25

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

138

1.59

1.25

1.4

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

354

3180

1.12

1.25

1.5

1.4

28.45

25.76

iu/l

0.71

283

2643

(3008536) Aspergillus sp Ab [Presence] in Serum

146

1.58

1.25

3.0

2.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

215

1872

1.15

1.24

5.3

4.2

—

(3002256) Pathology report gross observation

880

9379

0.93

1.24

1.2

1.3

—

(36660697) Celiac disease serology panel - Serum

654

6058

1.09

1.23

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.00

1.23

2.4

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

977

0.80

1.22

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

6517

64269

1.05

1.21

26.1

16.8

14.91

14.90

0.02

6444

63093

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.63

1.21

1.0

1.3

—

mmol/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

920

0.79

1.21

1.0

1.1

0.04

0.44

u/ml

3.24

306

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

524

0.72

1.20

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

213

1.46

1.19

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

324

0.65

1.19

1.6

1.5

5.75

4.05

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

400

1.33

1.19

1.6

1.5

1.08

1.21

nmol/l

0.58

304

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

255

1.41

1.19

1.3

1.2

—

(40761536) Microorganisms panel - Urine sediment

678

6302

1.08

1.18

4.6

3.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.74

1.18

2.3

4.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

392

1.33

1.18

25.6

26.5

109.21

118.09

ug/l

0.49

327

(3009542) Hematocrit [Volume Fraction] of Blood

8215

82696

0.94

1.18

33.2

20.8

39.33

40.41

17.13

7666

77497

(3007461) Platelets [#/volume] in Blood

8220

82744

0.94

1.18

33.1

20.7

248.18

249.76

e9/l

1.30

8070

80503

(3037692) Legionella sp identified in Specimen by Organism specific culture

247

1.42

1.18

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

953

10107

0.94

1.17

1.4

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.88

1.17

2.2

1.7

9.50

3.59

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.88

1.17

2.2

1.7

2.48

1.60

mg/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.88

1.17

1.2

2.28

1.61

umol/24h

0.63

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.88

1.17

2.2

1.7

0.57

1.49

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.88

1.17

2.2

1.7

0.76

0.94

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.88

1.17

2.2

1.7

1.26

0.99

mg/l

—

(3044009) aPTT.lupus sensitive (LA screen)

1.88

1.17

1.1

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

181

1.49

1.17

1.1

1.3

16.07

16.73

umol/l

0.28

165

(3011841) English Walnut IgE Ab [Units/volume] in Serum

126

0.48

1.16

1.0

1.1

0.03

9.01

u/ml

—

105

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

127

0.47

1.16

1.0

1.2

0.15

5.04

u/ml

—

103

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.50

1.15

1.4

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.05

1.15

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

118

1.61

1.14

1.5

1.7

110.58

144.40

ng/l

0.58

118

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.33

1.12

1.0

1.2

217.86

304.81

nmol/l

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

250

1.40

1.12

1.9

2.1

650.55

3761.04

e6/l

0.52

178

(21494434) Karyotype in Bone marrow

636

1.24

1.10

1.3

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

645

1.24

1.10

4.0

4.9

267.96

67.46

u/ml

0.68

192

(3021879) Hepatitis B virus core Ab [Presence] in Serum

608

5648

1.08

1.10

1.5

1.4

—

(3017400) Magnesium [Moles/volume] in Urine

2.38

1.09

1.0

2.79

mmol/l

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.38

1.09

1.0

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

104

1.64

1.09

1.3

1.8

—

(40768446) Kidney Pathology biopsy report

320

1.34

1.08

1.7

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.19

1.08

1.0

1.1

—

23.61

—

(3003338) MCHC [Mass/volume]

6469

63855

1.04

1.07

29.3

17.9

334.21

332.73

g/l

29.88

6416

63296

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.79

1.04

2.2

1.7

0.98

1.13

mg/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

154

1330

1.16

1.04

3.2

3.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

246

1.38

1.02

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

138

1.52

1.02

1.4

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

190

0.58

1.02

1.6

1.9

—

140.85

—

(3045414) Leukocytes [Presence] in Urine

357

3253

1.10

1.02

1.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

402

3685

1.09

1.01

1.2

1.1

130.56

177.65

titre

—

104

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

163

1.47

1.01

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

519

1.25

1.00

2.6

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

528

1.25

1.00

2.2

1.6

31.94

22.46

u/ml

0.85

118

(3025941) Bacteria identified in Stool by Culture

454

4187

1.09

1.00

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

179

2036

0.88

0.99

1.1

5.77

7.74

u/ml

0.27

252

(1002224) Polysomnography panel

263

2921

0.90

0.99

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2022

19534

1.04

0.99

4.1

3.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

116

984

1.18

0.99

1.1

1.50

1.51

g/l

0.08

109

883

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

164

1.46

0.98

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

124

1447

0.85

0.98

1.1

0.51

1.14

u/ml

2.52

709

(3009677) Dengue virus Ab [Presence] in Serum

2.17

0.98

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

128

1489

0.86

0.98

1.1

3.98

6.46

u/ml

1.60

838

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

223

1.39

0.98

1.5

1.9

13508.90

15952.10

e6/l

0.07

124

(40768793) Breast Pathology biopsy report

119

1391

0.85

0.97

1.3

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

140

1.50

0.97

1.0

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

406

1.28

0.96

1.5

1.4

5.00

4.60

umol/l

0.33

375

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.96

0.0

1.0

—

(3045142) Bone marrow Pathology biopsy report

822

1.19

0.95

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

488

1.25

0.94

1.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

514

4780

1.08

0.94

1.9

2.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.77

0.94

1.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

217

1.38

0.92

1.3

58.00

55.21

0.15

181

(3004716) Salmonella sp identified in Stool by Organism specific culture

401

3695

1.09

0.92

1.3

—

(3035880) pH of Pleural fluid

418

1.27

0.92

1.2

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

134

1.49

0.91

1.9

1.6

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.07

0.89

1.2

1.00

1.29

u/field

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1035

0.84

0.89

1.1

6.99

5.74

u/ml

0.16

454

(3045683) HLA typing for celiac disease panel - Blood or Tissue

439

0.75

0.88

1.0

—

(4212803) Bone marrow aspirate examination

1.69

0.88

1.1

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

394

1.27

0.88

1.3

1.8

—

(3017704) Immunofixation for Urine

394

1.27

0.88

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

394

1.27

0.88

1.3

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

171

1931

0.88

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

832

1.18

0.86

1.4

1.3

—

(3000012) Reticulocyte production index

122

1056

1.16

0.84

2.4

2.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.78

0.84

1.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6890

68224

1.04

0.83

19.5

13.2

86.37

81.68

ml/min/173m2

51.20

5868

56178

(3002523) Influenza virus A Ag [Presence] in Specimen

104

1209

0.86

0.82

1.1

—

(40768795) Lymph node Pathology biopsy report

700

0.81

0.82

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

410

3804

1.08

0.82

1.8

1.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

388

0.75

0.82

2.0

155.33

184.59

ug/min

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.74

0.82

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

960

0.84

0.81

2.1

2.7

4.84

8.56

umol/l

2.83

713

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

904

8615

1.05

0.80

4.3

4.4

32.54

32.26

0.30

653

5953

(3025018) Bordetella pertussis Ab [Titer] in Serum

476

0.78

0.80

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

700

1.19

0.80

1.3

1.4

6.23

6.39

mmol/l

0.26

642

(40768797) Stomach Pathology biopsy report

1024

9793

1.05

0.80

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

881

0.84

0.79

1.1

1.4

2.84

4.78

ug/l

2.40

790

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.79

0.0

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

619

0.81

0.79

1.2

1.3

202.95

186.49

pmol/l

0.16

619

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.62

0.78

1.1

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

483

1.22

0.78

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.56

0.78

1.4

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

666

1.19

0.77

1.4

1.3

138503.74

117280.92

e6/l

0.11

455

(3012516) Albumin [Mass/volume] in Urine

2047

21048

0.96

0.77

3.3

515.22

390.32

mg/l

0.53

1386

13713

(3007463) Buprenorphine [Presence] in Urine

1.76

0.76

3.0

5.8

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.76

0.0

1.1

—

0.22

—

(3003740) Influenza virus B Ag [Presence] in Specimen

105

1209

0.87

0.75

1.1

—

(3044941) Cell count panel - Synovial fluid

1121

0.86

0.74

1.4

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.84

0.73

1.1

1.4

22.40

23.77

pmol/l

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.64

0.73

1.0

2.4

—

76.90

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

140

1240

1.13

0.73

1.5

1.6

0.66

0.79

g/l

0.88

106

947

(3005322) IgE [Units/volume] in Serum or Plasma

499

4690

1.07

0.73

1.3

142.28

243.75

u/ml

5.51

458

4349

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

903

0.85

0.71

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

117

1.45

0.71

1.2

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

139

1234

1.13

0.70

1.1

—

(40758358) Immune stain study

1.85

0.68

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.53

0.68

1.1

1.2

10.89

15.53

u/l

—

(4281824) Cell count and differential, peritoneal fluid

692

0.84

0.67

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

828

1.15

0.65

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

213

0.70

0.64

1.0

21.61

11.68

u/ml

—

123

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

140

1253

1.12

0.64

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

242

2624

0.92

0.63

1.6

1.7

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

129

1.40

0.63

1.2

1.1

—

5.01

—

(3023420) DNA double strand Ab [Units/volume] in Serum

747

1.15

0.62

2.2

1.4

30.20

24.39

iu/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

279

1.25

0.62

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.59

0.61

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.67

0.61

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

739

1.15

0.61

1.6

2.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

147

1.36

0.61

1.1

1.2

1.73

1.60

mmol/l

0.24

(3029634) Reagin Ab [Titer] in Serum by VDRL

123

1097

1.12

0.61

2.3

2.0

2.40

8.13

titre

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

445

4709

0.94

0.60

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.60

0.0

7.7

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.1

—

220.81

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.54

0.59

1.1

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.56

0.58

1.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

17.53

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

115

0.61

0.57

1.3

3.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.48

0.56

1.2

1.0

—

(3022670) pH of Venous cord blood

1.67

0.56

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

680

1.15

0.56

3.4

3.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.54

0.55

1.6

54.90

43.51

umol/l

—

(3014891) Appearance of Pleural fluid

107

1.40

0.55

1.4

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

427

0.82

0.54

1.3

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

215

2320

0.92

0.53

1.6

1.5

77.95

6.54

iu/ml

0.62

503

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

608

1.15

0.53

5.3

3.5

56.79

43.39

u/ml

0.22

600

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

178

1.29

0.52

5.6

5.7

69.56

71.68

0.18

139

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.62

0.52

1.2

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

180

1.28

0.49

1.3

1.1

19.96

20.17

mmol/l

0.07

160

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

445

1.17

0.49

1.5

1.6

6.52

6.69

u/l

0.04

361

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

181

1673

1.08

0.48

1.6

1.8

3.65

4.49

iu/l

0.67

588

(3038026) Centromere Ab [Units/volume] in Serum

549

1.15

0.48

1.3

1.2

23.44

50.95

u/ml

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

376

0.82

0.47

7.7

5.4

1645.33

10016.13

u/ml

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

376

0.82

0.47

5.1

4.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1077

0.90

0.46

1.3

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

277

0.79

0.46

1.6

1.5

—

(3021788) Differential panel - Synovial fluid

118

1296

0.91

0.46

1.6

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1893

19310

0.97

0.45

2.9

2.7

3194.85

4385.23

umol/l

0.72

1628

16927

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.38

0.45

1.2

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.59

0.45

1.2

1.3

—

(3015183) Erythrocyte sedimentation rate

363

0.83

0.45

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.40

0.45

3.9

4.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1170

11387

1.03

0.44

1.7

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.45

0.44

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

852

0.89

0.44

1.8

1.5

56.16

59.29

0.33

549

(3047189) Immunofixation for 24 hour Urine

351

0.83

0.44

1.2

1.7

—

(3049717) Cytology report of Urine Cyto stain

296

2799

1.06

0.43

2.3

2.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

184

1.25

0.43

1.3

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.61

0.43

1.0

1.5

27.46

21.09

nmol/l

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.65

0.42

15.5

7.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.64

0.42

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

701

0.88

0.42

3.2

3.0

82.49

54.97

mg/l

0.27

533

(3038071) Oxygen [Partial pressure] in Mixed venous blood

195

0.77

0.41

6.6

7.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

258

1.20

0.41

1.4

1.2

0.31

0.30

g/l

0.25

208

(3024263) Appearance of Synovial fluid

391

0.84

0.41

1.2

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

231

1.21

0.41

2.0

3.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.40

0.0

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

131

1207

1.09

0.40

1.4

1.2

62.08

38.32

u/l

0.64

115

1053

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

653

1.12

0.40

1.5

1.3

1.49

1.47

nmol/l

0.04

589

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

115

1.30

0.38

1.4

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

181

1693

1.07

0.38

1.3

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.39

0.38

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

334

0.84

0.38

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

194

2065

0.94

0.38

1.4

—

(3033799) Differential panel - Peritoneal fluid

224

1.21

0.38

2.3

1.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

599

1.12

0.37

2.0

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

515

0.87

0.37

1.1

11.78

9.71

iu/ml

—

119

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

533

1.13

0.37

1.3

1.2

57.67

71.67

u/ml

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

113

0.71

0.37

1.0

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

161

1.24

0.36

1.5

0.32

0.41

ug/l

0.56

(3025577) Chromium [Mass/volume] in Blood

439

0.86

0.36

1.9

2.1

2.09

2.35

ug/l

0.26

365

(3006270) Folate [Moles/volume] in Blood

649

1.11

0.36

1.1

1.2

314.35

357.24

nmol/l

1.19

539

(3042733) HLA Ab [Presence] in Serum

263

1.18

0.35

4.6

—

(3010937) Rubella virus Ab [Presence] in Serum

1.43

0.35

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

385

3692

1.04

0.35

4.2

3.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

575

0.89

0.35

1.1

1.2

—

(4146454) Self-monitoring of blood glucose

764

0.90

0.35

2.3

2.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

537

1.12

0.34

1.3

1.2

25.43

46.85

u/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

691

7111

0.97

0.34

1.6

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

282

2688

1.05

0.34

2.1

1.8

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

218

1.19

0.34

1.1

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

690

1.10

0.34

1.2

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

272

2592

1.05

0.33

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

100

1.30

0.33

1.1

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

157

1670

0.94

0.32

1.2

1.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

512

1.11

0.31

1.3

1.2

2.83

12.11

u/ml

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

853

8735

0.97

0.31

2.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

441

0.88

0.29

1.2

1.3

1.55

1.53

g/l

0.08

441

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

192

1821

1.06

0.29

2.3

179.69

108.18

ug/min

1.20

106

1107

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

231

1.17

0.29

4.1

6.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

141

0.78

0.29

1.1

2.0

1.85

2.03

ug/l

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

159

1501

1.06

0.29

1.5

1.6

106.55

114.42

u/ml

0.45

297

(3025130) Human papilloma virus identified in Specimen

816

0.92

0.29

1.5

1.7

—

(3024471) HLA-A [Type]

269

1.15

0.29

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

121

1.24

0.28

1.5

1.6

—

(40768443) Skin Pathology biopsy report

332

3196

1.04

0.28

1.2

—

(3048879) Bone marrow aspiration report

205

0.83

0.28

2.1

1.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

174

1650

1.06

0.27

1.6

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

796

1.08

0.27

1.3

0.40

g/l

0.00

562

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

318

1.13

0.27

1.0

1.1

1.60

6.57

u/ml

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

797

1.08

0.27

1.3

6.50

6.67

g/l

0.14

562

(3028192) IgG subclass 2 [Mass/volume] in Serum

797

1.08

0.27

1.3

2.80

2.86

g/l

0.09

565

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

461

1.11

0.26

1.8

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

169

1605

1.05

0.26

1.3

1.4

259.87

256.48

u/ml

0.06

112

970

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

362

0.88

0.25

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

181

0.83

0.25

1.1

1.4

—

(4062490) Immunoglobulin typing, IgG

800

1.08

0.25

1.3

—

(3006462) Nitrate [Presence] in Urine

349

1.12

0.24

2.3

3.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

217

1.15

0.24

1.7

2.5

255.66

119.75

ng/l

0.46

146

(3009871) Measles virus Ab [Titer] in Serum

233

0.86

0.23

1.8

1.7

—

(3024932) HLA-DR beta [Type]

265

1.13

0.23

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.32

0.23

1.0

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.28

0.23

1.0

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.25

0.22

1.0

1.6

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

467

1.09

0.22

1.4

113.33

322.14

titre

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

266

2569

1.04

0.21

3.0

3.5

175.56

2693.49

u/ml

1.54

228

2188

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.21

0.0

1.8

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

156

0.83

0.21

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

136

1427

0.95

0.21

1.3

1.2

59.92

39.93

u/ml

0.67

139

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

12.62

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

7.0

—

0.27

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

70.69

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

154

1.17

0.21

1.4

2.1

5.95

8.00

mmol/l

2.78

(3020876) Protein [Mass/time] in 24 hour Urine

837

1.06

0.21

1.7

2.5

1.56

1.42

g/24h

0.16

423

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

40.13

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.21

0.0

7.9

—

60.60

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.20

0.0

7.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

171

1640

1.04

0.20

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

644

1.07

0.20

1.1

—

(3044007) Cell count panel - Peritoneal fluid

202

1.14

0.20

1.4

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

218

0.87

0.19

6.3

6.9

—

(3035933) Granulocytes/100 leukocytes in Blood

280

0.89

0.18

1.4

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

406

1.08

0.17

2.0

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.15

0.17

2.4

5.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

403

0.92

0.17

1.2

1.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.11

0.17

1.0

162.57

163.78

g/l

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.76

0.17

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

233

2400

0.97

0.17

1.4

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

309

0.91

0.17

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

236

0.89

0.16

2.1

1.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

120

1.17

0.16

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

408

1.08

0.16

2.0

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

255

2480

1.03

0.16

1.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.78

0.15

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

493

0.93

0.15

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.10

0.15

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

389

0.92

0.14

2.1

1.9

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

645

0.94

0.14

1.5

34.31

29.74

0.50

401

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

202

0.89

0.14

1.4

1.6

11.25

9.05

ug/l

0.62

202

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

179

1.12

0.14

2.1

1.9

0.08

0.20

nmol/l

1.76

126

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

181

1757

1.03

0.13

1.4

1.2

4.25

5.52

u/ml

0.21

166

(40765096) Chromosome analysis panel by Banding

222

0.90

0.13

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

499

0.94

0.13

1.3

0.29

3.24

u/ml

5.45

283

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

158

1534

1.03

0.12

1.9

2.0

0.87

0.80

nmol/l

0.67

127

1282

(3000285) Sodium [Moles/volume] in Blood

104

1.15

0.12

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

230

2246

1.02

0.12

1.4

1.3

182.92

217.07

miu/ml

0.71

1006

(3009508) Creatinine [Moles/volume] in Urine

2300

23128

0.99

0.12

3.4

3.3

7.50

7.74

mmol/l

1.61

1962

19612

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

137

0.88

0.12

1.1

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

106

1097

0.97

0.11

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

136

0.88

0.11

1.8

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

182

1778

1.02

0.10

1.4

1.3

13.72

8.67

u/ml

0.40

266

(44813793) Dust mix specific IgE antibody measurement

535

1.05

0.10

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.14

0.10

5.8

6.7

—

(3022689) Creatine [Moles/volume] in Urine

217

0.92

0.09

1.6

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

148

1445

1.02

0.09

1.3

1.2

1.51

4.06

u/ml

1.00

102

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.11

0.09

1.5

1.1

—

(40758292) HTLV I+II Ab panel - Serum

126

1.11

0.09

1.5

1.4

—

(3001729) Color of Synovial fluid

0.78

0.08

1.0

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.87

0.07

1.7

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.83

0.07

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

326

0.95

0.07

1.2

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

195

1919

1.02

0.06

1.4

1.2

49.86

36.66

u/ml

0.36

105

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4839

48456

1.00

0.06

3.1

3.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

607

6112

0.99

0.06

2.2

12.30

12.53

nmol/l

0.27

534

5451

(3004775) Volume in Urine collected for unspecified duration

597

0.97

0.05

2.2

2.3

682.39

638.93

0.31

396

(3013637) Mi-2 Ab [Presence] in Serum

178

1.07

0.05

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

178

1.07

0.05

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

178

1.07

0.05

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

178

1.07

0.05

1.0

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

146

1482

0.98

0.05

3.0

3.5

252.01

652.55

u/ml

1.10

132

1361

(3036670) Protein [Mass/volume] in Synovial fluid

218

1.05

0.05

1.4

1.2

40.75

39.07

g/l

0.22

119

(3000475) Leukocytes [#/volume] in Synovial fluid

176

1736

1.01

0.05

1.7

1.6

12674.06

15088.31

e6/l

0.47

125

1239

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

234

2364

0.99

0.04

1.7

1.8

47.51

40.44

nmol/l

2.43

228

2290

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

545

1.03

0.04

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

922

9177

1.00

0.04

2.1

2.5

161.11

132.88

ug/g

0.93

735

7306

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

418

1.03

0.03

6.1

6.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

160

1617

0.99

0.03

4.9

3.4

28.00

27.91

mg/l

0.01

102

1022

(3002619) Bacteria identified in Specimen by Culture

158

0.95

0.02

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

202

1.04

0.02

2.1

1.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

167

1680

0.99

0.01

1.9

196.85

202.69

pmol/l

0.30

156

1585

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

793

7911

1.00

0.01

2.0

—

(3006598) pH of Arterial cord blood

143

1.05

0.01

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

153

1.05

0.01

5.4

6.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

403

4039

1.00

0.01

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

323

3221

1.00

0.00

3.2

3.4

130.79

57.46

u/ml

0.37

312

3102

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

536

0.99

0.00

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

193

1936

1.00

0.00

2.4

2.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

178

1.01

0.00

3.3

2.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

170

1.00

0.00

1.6

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.02

0.00

14.9

12.7

4.81

5.69

mmol/l

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

532

1.00

0.00

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

532

1.00

0.00

1.3

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

137

1.02

0.00

7.0

7.7

—

(3051101) Glucose [Moles/volume] in Cord blood

123

0.98

0.00

6.2

6.9

—

(3016750) Collection duration of Urine

425

0.99

0.00

2.3

2.2

494.69

491.56

min

0.06

313

(3002621) Streptococcal DNAse B [Units/volume] in Serum

117

1.03

0.00

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

448

1.00

0.00

1.4

1.5

11.30

6.31

u/l

0.48

384

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

535

0.99

0.00

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

535

0.99

0.00

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

174

0.98

0.00

1.1

—

(40768441) Liver Pathology biopsy report

554

0.99

0.00

1.6

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

533

0.99

0.00

1.3

1.2

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.03

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.98

0.00

4.3

4.7

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

20.84

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

1.3

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

5.3

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.95

-0.00

1.3

1.2

—

577.74

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.01

-0.00

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.00

-0.00

1.3

1.4

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.85

-0.00

1.4

1.8

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

21.00

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.98

-0.00

1.0

23.70

13.52

u/ml

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.91

-0.00

1.1

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.97

-0.00

4.3

4.9

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint FE_STRICT and mortality.

Females

Parameter	HR [95% CI]	p-value
FE_STRICT	3.574 [3.23, 3.96]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.063

During the follow-up period (1.1.1998 — 31.12.2019), 9830 out of 29202 females with FE_STRICT died.

Males

Parameter	HR [95% CI]	p-value
FE_STRICT	3.485 [3.14, 3.87]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 12596 out of 33557 males with FE_STRICT died.

Mortality risk

Mortality risk for people of age

years, who have FE_STRICT.

N-year risk	Females	Males
1	0.289%	0.634%
5	1.789%	3.581%
10	4.845%	8.1%
15	9.14%	14.981%
20	15.75%	24.808%

Relationships between endpoints

↥

Index endpoint: FE_STRICT – Focal epilepsy, strict definition

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Focal epilepsy, strict definition

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints